Prof Robert Moots BSc (hons), MB BS (hons), PhD, FRCP

Professor of Rheumatology (Clin,Hcc) Musculoskeletal Biology I

    Publications

    2019

    Rheumatology in India: Yesterday, today, and tomorrow? (Journal article)

    Moots, R. J. (2019). Rheumatology in India: Yesterday, today, and tomorrow?. Indian Journal of Rheumatology, 14(4), 263-264. doi:10.4103/0973-3698.274457

    DOI: 10.4103/0973-3698.274457

    A novel treatment in the management of genital ulceration in Behcet's disease (Journal article)

    Benson, R. M., Kirwan, J., & Moots, R. J. (2019). A novel treatment in the management of genital ulceration in Behcet's disease. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 37(6), 158. Retrieved from http://gateway.webofknowledge.com/

    Patient-reported outcomes for tofacitinib with and without methotrexate, or adalimumab with methotrexate, in rheumatoid arthritis: A phase IIIB/IV trial (Journal article)

    Strand, V., Mysler, E., Moots, R. J., Wallenstein, G. V., Demasi, R., Gruben, D., . . . Fleischmann, R. (2019). Patient-reported outcomes for tofacitinib with and without methotrexate, or adalimumab with methotrexate, in rheumatoid arthritis: A phase IIIB/IV trial. RMD Open, 5(2). doi:10.1136/rmdopen-2019-001040

    DOI: 10.1136/rmdopen-2019-001040

    Smoking does not protect patients with axial spondyloarthritis from attacks of uveitis (Journal article)

    Zhao, S. S., Macfarlane, G. J., Jones, G. T., Gaffney, K., Hughes, D. M., Moots, R. J., & Goodson, N. J. (2019). Smoking does not protect patients with axial spondyloarthritis from attacks of uveitis. ANNALS OF THE RHEUMATIC DISEASES, 78(9), 1287-+. doi:10.1136/annrheumdis-2019-215348

    DOI: 10.1136/annrheumdis-2019-215348

    Smoking status and cause-specific discontinuation of tumour necrosis factor inhibitors in axial spondyloarthritis (Journal article)

    Zhao, S. S., Yoshida, K., Jones, G. T., Hughes, D. M., Duffield, S. J., Tedeschi, S. K., . . . Goodson, N. J. (2019). Smoking status and cause-specific discontinuation of tumour necrosis factor inhibitors in axial spondyloarthritis. ARTHRITIS RESEARCH & THERAPY, 21. doi:10.1186/s13075-019-1958-z

    DOI: 10.1186/s13075-019-1958-z

    The role of IL-17A in axial spondyloarthritis and psoriatic arthritis: recent advances and controversies (Journal article)

    McGonagle, D. G., McInnes, I. B., Kirkham, B. W., Sherlock, J., & Moots, R. (2019). The role of IL-17A in axial spondyloarthritis and psoriatic arthritis: recent advances and controversies. ANNALS OF THE RHEUMATIC DISEASES, 78(9), 1167-1178. doi:10.1136/annrheumdis-2019-215356

    DOI: 10.1136/annrheumdis-2019-215356

    EFFICACY OF TOFACITINIB MONOTHERAPY, TOFACITINIB WITH METHOTREXATE AND ADALIMUMAB WITH METHOTREXATE IN PATIENTS WITH EARLY (<= 2 YEARS) VS ESTABLISHED (> 2 YEARS) RHEUMATOID ARTHRITIS: A POST HOC ANALYSIS OF DATA FROM ORAL STRATEGY (Conference Paper)

    Takeuchi, T., Tanaka, Y., Sugiyama, N., Iikuni, N., Soma, K., Shi, H., . . . Fleischmann, R. (2019). EFFICACY OF TOFACITINIB MONOTHERAPY, TOFACITINIB WITH METHOTREXATE AND ADALIMUMAB WITH METHOTREXATE IN PATIENTS WITH EARLY (<= 2 YEARS) VS ESTABLISHED (> 2 YEARS) RHEUMATOID ARTHRITIS: A POST HOC ANALYSIS OF DATA FROM ORAL STRATEGY. In ANNALS OF THE RHEUMATIC DISEASES Vol. 78 (pp. 373-374). doi:10.1136/annrheumdis-2019-eular.587

    DOI: 10.1136/annrheumdis-2019-eular.587

    PSYCHOLOGICAL EFFECTS OF A BEHCET'S DIAGNOSIS ON DISEASE ACTIVITY PERCEPTION- A PROSPECTIVE OBSERVATIONAL STUDY (Conference Paper)

    Buzatu, C., Nicholson, H., Cunningham, R., & Moots, R. J. (2019). PSYCHOLOGICAL EFFECTS OF A BEHCET'S DIAGNOSIS ON DISEASE ACTIVITY PERCEPTION- A PROSPECTIVE OBSERVATIONAL STUDY. In ANNALS OF THE RHEUMATIC DISEASES Vol. 78 (pp. 569). doi:10.1136/annrheumdis-2019-eular.6274

    DOI: 10.1136/annrheumdis-2019-eular.6274

    THE CLINICAL UTILITY OF TWO VASCULITIS ACTIVITY SCORES(BVAS AND BDCAF) IN BEHCET'S SYNDROME: A PROSPECTIVE COHORT STUDY (Conference Paper)

    Buzatu, C., Duffield, S., Chadwick, L., & Moots, R. J. (2019). THE CLINICAL UTILITY OF TWO VASCULITIS ACTIVITY SCORES(BVAS AND BDCAF) IN BEHCET'S SYNDROME: A PROSPECTIVE COHORT STUDY. In ANNALS OF THE RHEUMATIC DISEASES Vol. 78 (pp. 567). doi:10.1136/annrheumdis-2019-eular.6197

    DOI: 10.1136/annrheumdis-2019-eular.6197

    Comparison of comorbidities and treatment between ankylosing spondylitis and non-radiographic axial spondyloarthritis in the United States (Journal article)

    Zhao, S. S., Ermann, J., Xu, C., Lyu, H., Tedeschi, S. K., Liao, K. P., . . . Solomon, D. H. (2019). Comparison of comorbidities and treatment between ankylosing spondylitis and non-radiographic axial spondyloarthritis in the United States. RHEUMATOLOGY, 58(11), 2025-2030. doi:10.1093/rheumatology/kez171

    DOI: 10.1093/rheumatology/kez171

    Pain and depression are associated with both physical and mental fatigue independently of comorbidities and medications in primary Sjögren's syndrome. (Journal article)

    Hackett, K. L., Davies, K., Tarn, J., Bragg, R., Hargreaves, B., Miyamoto, S., . . . Ng, W. -F. (2019). Pain and depression are associated with both physical and mental fatigue independently of comorbidities and medications in primary Sjögren's syndrome.. RMD open, 5(1), e000885. doi:10.1136/rmdopen-2018-000885

    DOI: 10.1136/rmdopen-2018-000885

    Biosimilars in the Americas: the future by consensus (Journal article)

    Moots, R. J. (2019). Biosimilars in the Americas: the future by consensus. CLINICAL RHEUMATOLOGY, 38(5), 1497-1499. doi:10.1007/s10067-019-04549-7

    DOI: 10.1007/s10067-019-04549-7

    Comorbidity burden in axial spondyloarthritis: a cluster analysis (Journal article)

    Zhao, S. S., Radner, H., Siebert, S., Duffield, S. J., Thong, D., Hughes, D. M., . . . Goodson, N. J. (2019). Comorbidity burden in axial spondyloarthritis: a cluster analysis. RHEUMATOLOGY, 58(10), 1746-1754. doi:10.1093/rheumatology/kez119

    DOI: 10.1093/rheumatology/kez119

    APPA INHIBITS NEUTROPHIL PRO-INFLAMMATORY FUNCTIONS WITHOUT IMPAIRING HOST DEFENCE: IS THIS A POTENTIAL NEW THERAPY FOR ARTHRITIS? (Conference Paper)

    Cross, A. L., Hawkes, J. J., Wright, H. L., Moots, R. J., & Edwards, S. W. (2019). APPA INHIBITS NEUTROPHIL PRO-INFLAMMATORY FUNCTIONS WITHOUT IMPAIRING HOST DEFENCE: IS THIS A POTENTIAL NEW THERAPY FOR ARTHRITIS?. In RHEUMATOLOGY Vol. 58 (pp. 46). Retrieved from http://gateway.webofknowledge.com/

    MEASURING THE IMPACT OF MUSCULOSKELETAL DISORDERS, WITH AND WITHOUT OTHER MORBIDITIES, ON STOPPING WORK BEFORE STATE PENSION AGE: A RETROSPECTIVE NESTED CASE-CONTROL STUDY (Conference Paper)

    Duffield, S. J., Walker-Bone, K., Moots, R. J., & Goodson, N. J. (2019). MEASURING THE IMPACT OF MUSCULOSKELETAL DISORDERS, WITH AND WITHOUT OTHER MORBIDITIES, ON STOPPING WORK BEFORE STATE PENSION AGE: A RETROSPECTIVE NESTED CASE-CONTROL STUDY. In RHEUMATOLOGY Vol. 58 (pp. 116). Retrieved from http://gateway.webofknowledge.com/

    MULTIMORBIDITY IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS: A CLUSTER ANALYSIS (Conference Paper)

    Zhao, S., Radner, H., Thong, D., Duffield, S. J., Hughes, D. M., Moots, R. J., . . . Siebert, S. (2019). MULTIMORBIDITY IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS: A CLUSTER ANALYSIS. In RHEUMATOLOGY Vol. 58. Retrieved from http://gateway.webofknowledge.com/

    PROTEOMIC ANALYSIS OF NEUTROPHIL EXTRACELLULAR TRAPS IN RHEUMATOID ARTHRITIS AND SYSTEMIC LUPUS ERYTHEMATOSUS (Journal article)

    Chapman, E. A., Lyon, M., Simpson, D., Mason, D., Beynon, R. J., Moots, R. J., & Wright, H. L. (2019). PROTEOMIC ANALYSIS OF NEUTROPHIL EXTRACELLULAR TRAPS IN RHEUMATOID ARTHRITIS AND SYSTEMIC LUPUS ERYTHEMATOSUS. RHEUMATOLOGY, 58. Retrieved from http://gateway.webofknowledge.com/

    Outcomes following mycophenolate mofetil versus cyclophosphamide induction treatment for proliferative juvenile-onset lupus nephritis. (Journal article)

    Smith, E., Al-Abadi, E., Armon, K., Bailey, K., Ciurtin, C., Davidson, J., . . . Hedrich, C. M. (2019). Outcomes following mycophenolate mofetil versus cyclophosphamide induction treatment for proliferative juvenile-onset lupus nephritis.. Lupus, 961203319836712. doi:10.1177/0961203319836712

    DOI: 10.1177/0961203319836712

    Caught in a Trap? Proteomic Analysis of Neutrophil Extracellular Traps in Rheumatoid Arthritis and Systemic Lupus Erythematosus (Journal article)

    Chapman, E. A., Lyon, M., Simpson, D., Mason, D., Beynon, R. J., Moots, R. J., & Wright, H. L. (2019). Caught in a Trap? Proteomic Analysis of Neutrophil Extracellular Traps in Rheumatoid Arthritis and Systemic Lupus Erythematosus. FRONTIERS IN IMMUNOLOGY, 10. doi:10.3389/fimmu.2019.00423

    DOI: 10.3389/fimmu.2019.00423

    Human neutrophils activated via TLR8 promote Th17 polarization through IL-23 (Journal article)

    Tamassia, N., Arruda-Silva, F., Wright, H. L., Moots, R. J., Gardiman, E., Bianchetto-Aguilera, F., . . . Cassatella, M. A. (2019). Human neutrophils activated via TLR8 promote Th17 polarization through IL-23. JOURNAL OF LEUKOCYTE BIOLOGY, 105(6), 1155-1165. doi:10.1002/JLB.MA0818-308R

    DOI: 10.1002/JLB.MA0818-308R

    The impact of smoking on response to TNF inhibitors in axial spondyloarthritis: methodological considerations for longitudinal observational studies. (Journal article)

    Zhao, S., Yoshida, K., Jones, G. T., Hughes, D. M., Tedeschi, S. K., Lyu, H., . . . Goodson, N. J. (2019). The impact of smoking on response to TNF inhibitors in axial spondyloarthritis: methodological considerations for longitudinal observational studies.. Arthritis care & research. doi:10.1002/acr.23851

    DOI: 10.1002/acr.23851

    Fatigue in primary Sjögren’s syndrome (pSS) is associated with lower levels of proinflammatory cytokines: a validation study (Journal article)

    Davies, K., Mirza, K., Tarn, J., Howard-Tripp, N., Bowman, S. J., Lendrem, D., . . . Ng, W. -F. (2019). Fatigue in primary Sjögren's syndrome (pSS) is associated with lower levels of proinflammatory cytokines: a validation study.. Rheumatology international, 39(11), 1867-1873. doi:10.1007/s00296-019-04354-0

    DOI: 10.1007/s00296-019-04354-0

    2018

    Measuring disease activity and response to treatment in rheumatoid arthritis. (Journal article)

    Buzatu, C., & Moots, R. J. (2019). Measuring disease activity and response to treatment in rheumatoid arthritis. EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 15(2), 135-145. doi:10.1080/1744666X.2019.1559050

    DOI: 10.1080/1744666x.2019.1559050

    Associations between smoking and extra-axial manifestations and disease severity in axial spondyloarthritis: results from the British Society for Rheumatology Biologics Register for Ankylosing Spondylitis (BSRBR-AS) (Journal article)

    Zhao, S., Jones, G. T., Macfarlane, G. J., Hughes, D. M., Dean, L. E., Moots, R. J., & Goodson, N. (2018). Associations between smoking and extra-axial manifestations and disease severity in axial spondyloarthritis: results from the British Society for Rheumatology Biologics Register for Ankylosing Spondylitis (BSRBR-AS). Rheumatology. doi:10.1093/rheumatology/key371

    DOI: 10.1093/rheumatology/key371

    Review of Biosimilar Trials and Data on Etanercept in Rheumatoid Arthritis (Journal article)

    Chadwick, L., Zhao, S., Mysler, E., & Moots, R. J. (2018). Review of Biosimilar Trials and Data on Etanercept in Rheumatoid Arthritis. CURRENT RHEUMATOLOGY REPORTS, 20(12). doi:10.1007/s11926-018-0799-0

    DOI: 10.1007/s11926-018-0799-0

    Rituximab in neurological disease: principles, evidence and practice. (Journal article)

    Whittam, D. H., Tallantyre, E. C., Jolles, S., Huda, S., Moots, R. J., Kim, H. J., . . . Jacob, A. (2019). Rituximab in neurological disease: principles, evidence and practice.. Practical neurology, 19(1), 5-20. doi:10.1136/practneurol-2018-001899

    DOI: 10.1136/practneurol-2018-001899

    Review of Biosimilar Trials and Data on Adalimumab in Rheumatoid Arthritis (Journal article)

    Zhao, S., Chadwick, L., Mysler, E., & Moots, R. J. (2018). Review of Biosimilar Trials and Data on Adalimumab in Rheumatoid Arthritis. CURRENT RHEUMATOLOGY REPORTS, 20(10). doi:10.1007/s11926-018-0769-6

    DOI: 10.1007/s11926-018-0769-6

    Management of major organ involvement of Behçet's syndrome: a systematic review for update of the EULAR recommendations. (Journal article)

    Ozguler, Y., Leccese, P., Christensen, R., Esatoglu, S. N., Bang, D., Bodaghi, B., . . . Hatemi, G. (2018). Management of major organ involvement of Behçet's syndrome: a systematic review for update of the EULAR recommendations.. Rheumatology (Oxford, England). doi:10.1093/rheumatology/key242

    DOI: 10.1093/rheumatology/key242

    B-cell activity markers are associated with different disease activity domains in primary Sjögren’s syndrome (Journal article)

    James, K., Chipeta, C., Parker, A., Harding, S., Cockell, S. J., Gillespie, C. S., . . . Fisher, B. A. (2018). B-cell activity markers are associated with different disease activity domains in primary Sjögren’s syndrome. Rheumatology, 57(7), 1222-1227. doi:10.1093/rheumatology/key063

    DOI: 10.1093/rheumatology/key063

    ASSOCIATIONS BETWEEN CLINICAL MANIFESTATIONS OF BEHCET'S SYNDROME AND WORK OUTCOMES: RESULTS FROM A UK CROSS-SECTIONAL ANALYSIS (Conference Paper)

    Chadwick, L., Goodson, N. J., & Moots, R. J. (2018). ASSOCIATIONS BETWEEN CLINICAL MANIFESTATIONS OF BEHCET'S SYNDROME AND WORK OUTCOMES: RESULTS FROM A UK CROSS-SECTIONAL ANALYSIS. In ANNALS OF THE RHEUMATIC DISEASES Vol. 77 (pp. 1161-1162). doi:10.1136/annrheumdis-2018-eular.4791

    DOI: 10.1136/annrheumdis-2018-eular.4791

    DIFFERENCES IN CLINICAL MANIFESTATIONS OF BEHCET'S SYNDROME BY GENDER: CROSS-SECTIONAL ANALYSIS IN A UK COHORT (Conference Paper)

    Chadwick, L., Blake, T., Goodson, N. J., Situnayake, D., & Moots, R. J. (2018). DIFFERENCES IN CLINICAL MANIFESTATIONS OF BEHCET'S SYNDROME BY GENDER: CROSS-SECTIONAL ANALYSIS IN A UK COHORT. In ANNALS OF THE RHEUMATIC DISEASES Vol. 77 (pp. 510). doi:10.1136/annrheumdis-2018-eular.3249

    DOI: 10.1136/annrheumdis-2018-eular.3249

    Efficacy and Safety Outcomes for Originator TNF Inhibitors and Biosimilars in Rheumatoid Arthritis and Psoriasis Trials: A Systematic Literature Review (Journal article)

    Moots, R. J., Curiale, C., Petersel, D., Rolland, C., Jones, H., & Mysler, E. (2018). Efficacy and Safety Outcomes for Originator TNF Inhibitors and Biosimilars in Rheumatoid Arthritis and Psoriasis Trials: A Systematic Literature Review. BIODRUGS, 32(3), 193-199. doi:10.1007/s40259-018-0283-4

    DOI: 10.1007/s40259-018-0283-4

    TOFACITINIB WITH AND WITHOUT METHOTREXATE VERSUS ADALIMUMAB WITH METHOTREXATE FOR THE TREATMENT OF RHEUMATOID ARTHRITIS: PATIENT-REPORTED OUTCOMES FROM A PHASE 3B/4 RANDOMISED TRIAL (Conference Paper)

    Strand, V., Mysler, E., Moots, R. J., Wallenstein, G., DeMasi, R., Gruben, D., . . . Fleischmann, R. (2018). TOFACITINIB WITH AND WITHOUT METHOTREXATE VERSUS ADALIMUMAB WITH METHOTREXATE FOR THE TREATMENT OF RHEUMATOID ARTHRITIS: PATIENT-REPORTED OUTCOMES FROM A PHASE 3B/4 RANDOMISED TRIAL. In ANNALS OF THE RHEUMATIC DISEASES Vol. 77 (pp. 990-991). doi:10.1136/annrheumdis-2018-eular.1312

    DOI: 10.1136/annrheumdis-2018-eular.1312

    2018 update of the EULAR recommendations for the management of Behçet’s syndrome (Journal article)

    Hatemi, G., Christensen, R., Bang, D., Bodaghi, B., Celik, A. F., Fortune, F., . . . Yazici, H. (n.d.). 2018 update of the EULAR recommendations for the management of Behçet’s syndrome. Annals of the Rheumatic Diseases, annrheumdis-2018-213225. doi:10.1136/annrheumdis-2018-213225

    DOI: 10.1136/annrheumdis-2018-213225

    Regional differences in baseline disease activity and remission rates following golimumab treatment for RA: results from the GO-MORE trial (Journal article)

    Durez, P., Pavelka, K., Alicia Lazaro, M., Garcia-Kutzbach, A., Moots, R. J., Amital, H., . . . Vastesaeger, N. (2018). Regional differences in baseline disease activity and remission rates following golimumab treatment for RA: results from the GO-MORE trial. CLINICAL RHEUMATOLOGY, 37(5), 1417-1420. doi:10.1007/s10067-018-4074-6

    DOI: 10.1007/s10067-018-4074-6

    RHEUMATOID ARTHRITIS NEUTROPHIL EXTRACELLULAR TRAPS CONTAIN CITRULLINATED HISTONE-H3 (Conference Paper)

    Lyon, M. A., Chapman, E. A., Moots, R. J., & Wright, H. L. (2018). RHEUMATOID ARTHRITIS NEUTROPHIL EXTRACELLULAR TRAPS CONTAIN CITRULLINATED HISTONE-H3. In RHEUMATOLOGY Vol. 57. Retrieved from http://gateway.webofknowledge.com/

    TAKAYASU'S ARTERITIS OR COCAINE INDUCED VASCULITIS? A CASE OF SEVERE NECROTIC OROFACIAL AND SCALP ULCERATION (Conference Paper)

    Chadwick, L., Nair, J., & Moots, R. J. (2018). TAKAYASU'S ARTERITIS OR COCAINE INDUCED VASCULITIS? A CASE OF SEVERE NECROTIC OROFACIAL AND SCALP ULCERATION. In RHEUMATOLOGY Vol. 57. Retrieved from http://gateway.webofknowledge.com/

    THE EFFECT OF JAK INHIBITION ON NEUTROPHIL KILLING, NETOSIS AND METABOLISM IN RHEUMATOID ARTHRITIS (Conference Paper)

    Chokesuwattanaskul, S., Mangalakumaran, S., Chapman, E., Cross, A., Phelan, M. M., Lian, L. -Y., . . . Wright, H. L. (2018). THE EFFECT OF JAK INHIBITION ON NEUTROPHIL KILLING, NETOSIS AND METABOLISM IN RHEUMATOID ARTHRITIS. In RHEUMATOLOGY Vol. 57. Retrieved from http://gateway.webofknowledge.com/

    Etanercept for the treatment of rheumatoid arthritis. (Journal article)

    Zhao, S., Mysler, E., & Moots, R. J. (2018). Etanercept for the treatment of rheumatoid arthritis. IMMUNOTHERAPY, 10(6), 433-445. doi:10.2217/imt-2017-0155

    DOI: 10.2217/imt-2017-0155

    Mycophenolate for persistent complex regional pain syndrome, a parallel, open, randomised, proof of concept trial (Journal article)

    Goebel, A., Jacob, A., Frank, B., Sacco, P., Alexander, G., Philips, C., . . . Moots, R. (2018). Mycophenolate for persistent complex regional pain syndrome, a parallel, open, randomised, proof of concept trial. Scandinavian Journal of Pain, 18(1), 29-37. doi:10.1515/sjpain-2017-0154

    DOI: 10.1515/sjpain-2017-0154

    Comparison of ESSDAI and ClinESSDAI in potential optimisation of trial outcomes in primary Sjögren's syndrome: examination of data from the UK Primary Sjögren's Syndrome Registry. (Journal article)

    Alexandre, D., Wan-Fai, N., Katherine, J., Bridget, G., Elizabeth, P., Colin, P. T., . . . Regis, U. K. P. S. S. (2018). Comparison of ESSDAI and ClinESSDAI in potential optimisation of trial outcomes in primary Sjogren's syndrome: examination of data from the UK Primary Sjogren's Syndrome Registry. SWISS MEDICAL WEEKLY, 148. doi:10.4414/smw.2018.14588

    DOI: 10.4414/smw.2018.14588

    Assessing the sensitivity of ISG and PEDBD criteria in a UK cohort of children and young people with Behcet's disease (Conference Paper)

    Pain, C. E., Latham, E., Beresford, M. W., Fortune, F., Moots, R. J., Murphy, R., . . . Brogan, P. (2018). Assessing the sensitivity of ISG and PEDBD criteria in a UK cohort of children and young people with Behcet's disease. In CLINICAL AND EXPERIMENTAL RHEUMATOLOGY Vol. 36 (pp. S186). Retrieved from http://gateway.webofknowledge.com/

    Management of skin, mucosa and joint involvement of Behcet's syndrome: A systematic review for update of the EULAR recommendations for the management of Behcet's syndrome (Journal article)

    Leccese, P., Ozguler, Y., Christensen, R., Esatoglu, S. N., Bang, D., Bodaghi, B., . . . Hatemi, G. (2019). Management of skin, mucosa and joint involvement of Behcet's syndrome: A systematic review for update of the EULAR recommendations for the management of Behcet's syndrome. SEMINARS IN ARTHRITIS AND RHEUMATISM, 48(4), 752-762. doi:10.1016/j.semarthrit.2018.05.008

    DOI: 10.1016/j.semarthrit.2018.05.008

    2017

    Effect of rituximab on a salivary gland ultrasound score in primary Sjogren's syndrome: results of the TRACTISS randomised double- blind multicentre substudy (Journal article)

    Fisher, B. A., Everett, C. C., Rout, J., O'Dwyer, J. L., Emery, P., Pitzalis, C., . . . Bowman, S. J. (2018). Effect of rituximab on a salivary gland ultrasound score in primary Sjogren's syndrome: results of the TRACTISS randomised double- blind multicentre substudy. ANNALS OF THE RHEUMATIC DISEASES, 77(3), 412-416. doi:10.1136/annrheumdis-2017-212268

    DOI: 10.1136/annrheumdis-2017-212268

    BRITISH PAEDIATRIC SURVEILLANCE UNIT (BPSU) STUDY OF BEHCET'S SYNDROME IN CHILDREN AND YOUNG PEOPLE IN THE UNITED KINGDOM (Conference Paper)

    Rice, H., Beresford, M. W., Brogan, P., Fortune, F., Moots, R. J., Murphy, R., & Pain, C. E. (2017). BRITISH PAEDIATRIC SURVEILLANCE UNIT (BPSU) STUDY OF BEHCET'S SYNDROME IN CHILDREN AND YOUNG PEOPLE IN THE UNITED KINGDOM. In RHEUMATOLOGY Vol. 56. Retrieved from http://gateway.webofknowledge.com/

    DEVELOPMENT OF A MULTI-DISCIPLINARY SERVICE FOR CHILDREN AND YOUNG PEOPLE WITH BEHCET'S SYNDROME: WITHIN THE LIVERPOOL NATIONAL CENTRE OF EXCELLENCE FOR BEHCET'S SYNDROME (Conference Paper)

    Pain, C. E., Al-Albadri, S., Heath, J., Porter, J., Rajlawat, B., Venkatesh, K., & Moots, R. J. (2017). DEVELOPMENT OF A MULTI-DISCIPLINARY SERVICE FOR CHILDREN AND YOUNG PEOPLE WITH BEHCET'S SYNDROME: WITHIN THE LIVERPOOL NATIONAL CENTRE OF EXCELLENCE FOR BEHCET'S SYNDROME. In RHEUMATOLOGY Vol. 56 (pp. 34-+). Retrieved from http://gateway.webofknowledge.com/

    Biosimilars: From Extrapolation into Off Label Use (Journal article)

    Zhao, S., Nair, J. R., & Moots, R. J. (2017). Biosimilars: From Extrapolation into Off Label Use. CURRENT PHARMACEUTICAL DESIGN, 23(44), 6746-6751. doi:10.2174/1381612824666171129193258

    DOI: 10.2174/1381612824666171129193258

    An Evaluation of Absolute Neutrophil Count As a Biomarker of Inflammatory and Clinical Disease Activity in Baricitinib-Treated Patients (Conference Paper)

    McInnes, I. B., Simon, L. S., Moots, R. J., Arora, V. K., Bradley, J. D., & Muram, D. (2017). An Evaluation of Absolute Neutrophil Count As a Biomarker of Inflammatory and Clinical Disease Activity in Baricitinib-Treated Patients. In ARTHRITIS & RHEUMATOLOGY Vol. 69. Retrieved from http://gateway.webofknowledge.com/

    Effect of Rituximab on a Salivary Gland Ultrasound Score in Primary Sjgren's Syndrome: Results of Multicentre Double-Blind Randomised Controlled Trial Sub-Study (Conference Paper)

    Fisher, B., Everett, C., Rout, J., O'Dwyer, J., Emery, P., Pitzalis, C., . . . Bowman, S. (2017). Effect of Rituximab on a Salivary Gland Ultrasound Score in Primary Sjgren's Syndrome: Results of Multicentre Double-Blind Randomised Controlled Trial Sub-Study. In ARTHRITIS & RHEUMATOLOGY Vol. 69. Retrieved from http://gateway.webofknowledge.com/

    Tofacitinib with and without Methotrexate Versus Adalimumab with Methotrexate for the Treatment of Rheumatoid Arthritis: Patient-Reported Outcomes from a Phase 3b/4 Randomized Trial (Conference Paper)

    Strand, V., Mysler, E., Moots, R. J., Wallenstein, G., DeMasi, R., Luo, Z., . . . Fleischmann, R. (2017). Tofacitinib with and without Methotrexate Versus Adalimumab with Methotrexate for the Treatment of Rheumatoid Arthritis: Patient-Reported Outcomes from a Phase 3b/4 Randomized Trial. In ARTHRITIS & RHEUMATOLOGY Vol. 69. Retrieved from http://gateway.webofknowledge.com/

    Janus kinase inhibitors prevent migration of rheumatoid arthritis neutrophils towards interleukin-8, but do not inhibit priming of the respiratory burst or reactive oxygen species production (Journal article)

    Mitchell, T. S., Moots, R. J., & Wright, H. L. (2017). Janus kinase inhibitors prevent migration of rheumatoid arthritis neutrophils towards interleukin-8, but do not inhibit priming of the respiratory burst or reactive oxygen species production. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 189(2), 250-258. doi:10.1111/cei.12970

    DOI: 10.1111/cei.12970

    Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase 3b/4, double-blind, head-to-head, randomised controlled trial (Journal article)

    Fleischmann, R., Mysler, E., Hall, S., Kivitz, A. J., Moots, R. J., Luo, Z., . . . Investigators, O. R. A. L. S. (2017). Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase 3b/4, double-blind, head-to-head, randomised controlled trial. LANCET, 390(10093), 457-468. doi:10.1016/S0140-6736(17)31618-5

    DOI: 10.1016/S0140-6736(17)31618-5

    The impact of anti-drug antibodies on drug concentrations and clinical outcomes in rheumatoid arthritis patients treated with adalimumab, etanercept, or infliximab: Results from a multinational, real-world clinical practice, non-interventional study (vol 12, e0175207, 2017) (Journal article)

    Moots, R. J., Xavier, R. M., Mok, C. C., Rahman, M. U., Tsai, W. -C., Al-Maini, M. H., . . . Vlahos, B. (2017). The impact of anti-drug antibodies on drug concentrations and clinical outcomes in rheumatoid arthritis patients treated with adalimumab, etanercept, or infliximab: Results from a multinational, real-world clinical practice, non-interventional study (vol 12, e0175207, 2017). PLOS ONE, 12(6). doi:10.1371/journal.pone.0179308

    DOI: 10.1371/journal.pone.0179308

    EFFECT OF RITUXIMAB ON A SALIVARY GLAND ULTRASOUND SCORE IN PRIMARY SJOGREN'S SYNDROME: RESULTS OF THE TRACTISS MULTICENTRE RANDOMISED TRIAL SUB-STUDY (Conference Paper)

    Fisher, B. A., Everett, C. C., Rout, J., O'Dywer, J. L., Emery, P., Pitzalis, C., . . . Bowman, S. J. (2017). EFFECT OF RITUXIMAB ON A SALIVARY GLAND ULTRASOUND SCORE IN PRIMARY SJOGREN'S SYNDROME: RESULTS OF THE TRACTISS MULTICENTRE RANDOMISED TRIAL SUB-STUDY. In ANNALS OF THE RHEUMATIC DISEASES Vol. 76 (pp. 1205-1206). doi:10.1136/annrheumdis-2017-eular.3138

    DOI: 10.1136/annrheumdis-2017-eular.3138

    Switching Between Reference Biologics and Biosimilars for the Treatment of Rheumatology, Gastroenterology, and Dermatology Inflammatory Conditions: Considerations for the Clinician. (Journal article)

    Moots, R., Azevedo, V., Coindreau, J. L., Dörner, T., Mahgoub, E., Mysler, E., . . . Marshall, L. (2017). Switching Between Reference Biologics and Biosimilars for the Treatment of Rheumatology, Gastroenterology, and Dermatology Inflammatory Conditions: Considerations for the Clinician.. Current rheumatology reports, 19(6), 37. doi:10.1007/s11926-017-0658-4

    DOI: 10.1007/s11926-017-0658-4

    Fibromyalgia in Behçet's disease: a narrative review. (Journal article)

    Jobanputra, C., Richey, R. H., Nair, J., Moots, R. J., & Goebel, A. (2017). Fibromyalgia in Behçet's disease: a narrative review.. British journal of pain, 11(2), 97-101. doi:10.1177/2049463717701393

    DOI: 10.1177/2049463717701393

    The impact of anti-drug antibodies on drug concentrations and clinical outcomes in rheumatoid arthritis patients treated with adalimumab, etanercept, or infliximab: Results from a multinational, real-world clinical practice, non-interventional study. (Journal article)

    Moots, R. J., Xavier, R. M., Mok, C. C., Rahman, M. U., Tsai, W. -C., Al-Maini, M. H., . . . Vlahos, B. (2017). The impact of anti-drug antibodies on drug concentrations and clinical outcomes in rheumatoid arthritis patients treated with adalimumab, etanercept, or infliximab: Results from a multinational, real-world clinical practice, non-interventional study. PLOS ONE, 12(4). doi:10.1371/journal.pone.0175207

    DOI: 10.1371/journal.pone.0175207

    METABOLIC ANALYSIS OF RHEUMATOID ARTHRITIS NEUTROPHILS: A NEW WAY TO MEASURE ACTIVATION OF CELLS IN DISEASE (Conference Paper)

    Chokesuwattanaskul, S., Phelan, M. M., Moots, R. J., Edwards, S. W., & Wright, H. L. (2017). METABOLIC ANALYSIS OF RHEUMATOID ARTHRITIS NEUTROPHILS: A NEW WAY TO MEASURE ACTIVATION OF CELLS IN DISEASE. In RHEUMATOLOGY Vol. 56 (pp. 146-147). Retrieved from http://gateway.webofknowledge.com/

    ROLE OF EXOGENOUS AND ENDOGENOUS TUMOUR NECROSIS FACTOR ALPHA IN THE REGULATION OF AN INTERFERON GENE EXPRESSION SIGNATURE IN RHEUMATOID ARTHRITIS NEUTROPHILS (Conference Paper)

    Makki, F. A., Wright, H. L., Moots, R. J., & Edwards, S. W. (2017). ROLE OF EXOGENOUS AND ENDOGENOUS TUMOUR NECROSIS FACTOR ALPHA IN THE REGULATION OF AN INTERFERON GENE EXPRESSION SIGNATURE IN RHEUMATOID ARTHRITIS NEUTROPHILS. In RHEUMATOLOGY Vol. 56 (pp. 145). Retrieved from http://gateway.webofknowledge.com/

    TYPE I INTERFERONS ALTER THE RESPONSE OF NEUTROPHILS TO INFLAMMATORY CYTOKINES (Conference Paper)

    Glennon-Alty, L., Moots, R. J., Edwards, S. W., & Wright, H. L. (2017). TYPE I INTERFERONS ALTER THE RESPONSE OF NEUTROPHILS TO INFLAMMATORY CYTOKINES. In RHEUMATOLOGY Vol. 56 (pp. 146). Retrieved from http://gateway.webofknowledge.com/

    The Behçet's centres of excellence: A new paradigm for care delivery in complex diseases. (Journal article)

    Moots, R. J., Fortune, F., & Situnayake, D. (2018). The Behcet's centres of excellence. RHEUMATOLOGY, 57(4), 594-595. doi:10.1093/rheumatology/kex037

    DOI: 10.1093/rheumatology/kex037

    Randomized Controlled Trial of Rituximab and cost-effectiveness analysis in treating fatigue and oral dryness in primary Sjogren's Syndrome. (Journal article)

    Bowman, S. J., Everett, C. C., O'Dwyer, J. L., Emery, P., Pitzalis, C., Ng, W. -F., . . . Bombardieri, M. (2017). Randomized Controlled Trial of Rituximab and Cost-Effectiveness Analysis in Treating Fatigue and Oral Dryness in Primary Sjogren's Syndrome. ARTHRITIS & RHEUMATOLOGY, 69(7), 1440-1450. doi:10.1002/art.40093

    DOI: 10.1002/art.40093

    Complementary and Alternative Medicine Use in Rheumatoid Arthritis: Considerations for the Pharmacological Management of Elderly Patients (Journal article)

    Zhao, S., Otieno, F., Akpan, A., & Moots, R. J. (2017). Complementary and Alternative Medicine Use in Rheumatoid Arthritis: Considerations for the Pharmacological Management of Elderly Patients. DRUGS & AGING, 34(4), 255-264. doi:10.1007/s40266-017-0443-0

    DOI: 10.1007/s40266-017-0443-0

    Behcet's disease (Journal article)

    Nair, J. R., & Moots, R. J. (2017). Behcet's disease. CLINICAL MEDICINE, 17(1), 71-77. doi:10.7861/clinmedicine.17-1-71

    Increasing smoking intensity is associated with increased disease activity in axial spondyloarthritis (Journal article)

    Zhao, S., Challoner, B., Khattak, M., Moots, R. J., & Goodson, N. J. (2017). Increasing smoking intensity is associated with increased disease activity in axial spondyloarthritis. RHEUMATOLOGY INTERNATIONAL, 37(2), 239-244. doi:10.1007/s00296-016-3590-4

    DOI: 10.1007/s00296-016-3590-4

    2016

    Building a rheumatology team for East Africa: A call for action! (Journal article)

    Genga, E. K., Moots, R. J., Oyoo, O. G., & Otieno, F. O. (2017). Building a rheumatology team for East Africa A call for action!. RHEUMATOLOGY, 56(9), 1441-1442. doi:10.1093/rheumatology/kew432

    DOI: 10.1093/rheumatology/kew432

    Physical activity but not sedentary activity is reduced in primary Sjogren's syndrome (Journal article)

    Ng, W. -F., Miller, A., Bowman, S. J., Price, E. J., Kitas, G. D., Pease, C., . . . Regi, U. K. P. S. S. (2017). Physical activity but not sedentary activity is reduced in primary Sjogren's syndrome. RHEUMATOLOGY INTERNATIONAL, 37(4), 623-631. doi:10.1007/s00296-016-3637-6

    DOI: 10.1007/s00296-016-3637-6

    Subjective and Objective Measures of Dryness Symptoms in Primary Sjögren's Syndrome - Capturing the discrepancy. (Journal article)

    Bezzina, O. M., Gallagher, P., Mitchell, S., Bowman, S. J., Griffiths, B., Hindmarsh, V., . . . Syndrome, U. K. P. S. (2017). Subjective and Objective Measures of Dryness Symptoms in Primary Sjogren's Syndrome: Capturing the Discrepancy. ARTHRITIS CARE & RESEARCH, 69(11), 1714-1723. doi:10.1002/acr.23165

    DOI: 10.1002/acr.23165

    Effect of tocilizumab on neutrophils in adult patients with rheumatoid arthritis: pooled analysis of data from phase 3 and 4 clinical trials (Journal article)

    Moots, R. J., Sebba, A., Rigby, W., Ostor, A., Porter-Brown, B., Donaldson, F., . . . Genovese, M. C. (2017). Effect of tocilizumab on neutrophils in adult patients with rheumatoid arthritis: pooled analysis of data from phase 3 and 4 clinical trials. RHEUMATOLOGY, 56(4), 541-549. doi:10.1093/rheumatology/kew370

    DOI: 10.1093/rheumatology/kew370

    Neutrophil biomarkers predict response to therapy with tumour necrosis factor inhibitors in rheumatoid arthritis (Journal article)

    Wright, H. L., Cox, T., Moots, R. J., & Edwards, S. W. (2016). Neutrophil biomarkers predict response to therapy with tumour necrosis factor inhibitors in rheumatoid arthritis. Journal of Leukocyte Biology. doi:10.1189/jlb.5A0616-258R

    DOI: 10.1189/jlb.5A0616-258R

    Switching to Biosimilars in Rheumatology: Evidence-Based Practice (Conference Paper)

    Moots, R. J., Azevedo, V. F., Dorner, T., Mysler, E., Scheinberg, M., Coindreau, J. L., . . . Marshall, L. (2016). Switching to Biosimilars in Rheumatology: Evidence-Based Practice. In ARTHRITIS & RHEUMATOLOGY Vol. 68. Retrieved from http://gateway.webofknowledge.com/

    a Systematic Literature Review on the Treatment of Skin, Mucosa and Joint Involvement of BehcEt's Syndrome Informing the Eular Recommendations for the Management of BehcEt's Syndrome (Conference Paper)

    Leccese, P., Ozguler, Y., Christensen, R., Esatoglu, S. N., Bang, D., Bodaghi, B., . . . Hatemi, G. (2016). a Systematic Literature Review on the Treatment of Skin, Mucosa and Joint Involvement of BehcEt's Syndrome Informing the Eular Recommendations for the Management of BehcEt's Syndrome. In ARTHRITIS & RHEUMATOLOGY Vol. 68. Retrieved from http://gateway.webofknowledge.com/

    Low-density granulocytes: functionally distinct, immature neutrophils in rheumatoid arthritis with altered properties and defective TNF signalling (Journal article)

    Wright, H. L., Makki, F. A., Moots, R. J., & Edwards, S. W. (2017). Low-density granulocytes: functionally distinct, immature neutrophils in rheumatoid arthritis with altered properties and defective TNF signalling. JOURNAL OF LEUKOCYTE BIOLOGY, 101(2), 599-611. doi:10.1189/jlb.5A0116-022R

    DOI: 10.1189/jlb.5A0116-022R

    MAVRILIMUMAB Human monoclonal GM-CSF-R-alpha antibody Treatment of rheumatoid arthritis MONOGRAPH (Book)

    Karumanchery, R., Nair, J. R., & Moots, R. J. (2016). MAVRILIMUMAB Human monoclonal GM-CSF-R-alpha antibody Treatment of rheumatoid arthritis MONOGRAPH (Vol. 41). doi:10.1358/dof.2016.041.04.2476061

    DOI: 10.1358/dof.2016.041.04.2476061

    Thoracic aortic aneurysms in Behcet's disease (Journal article)

    Fok, M., Bashir, M., Goodson, N., Oo, A., & Moots, R. (2017). Thoracic aortic aneurysms in Behcet's disease. RHEUMATOLOGY, 56(4), 501-502. doi:10.1093/rheumatology/kew226

    DOI: 10.1093/rheumatology/kew226

    Cost of dose escalation in people with rheumatoid arthritis treated with tumour necrosis factor inhibitors across Europe (Journal article)

    Holden, S. E., Currie, C. J., Lennon, M., Reynolds, A. V., & Moots, R. J. (2016). Cost of dose escalation in people with rheumatoid arthritis treated with tumour necrosis factor inhibitors across Europe. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 34(4), 679-684. Retrieved from http://gateway.webofknowledge.com/

    Prediction of remission and low disease activity in disease-modifying anti-rheumatic drug-refractory patients with rheumatoid arthritis treated with golimumab (Journal article)

    Vastesaeger, N., Kutzbach, A. G., Amital, H., Pavelka, K., Alicia Lazaro, M., Moots, R. J., . . . Durez, P. (2016). Prediction of remission and low disease activity in disease-modifying anti-rheumatic drug-refractory patients with rheumatoid arthritis treated with golimumab. RHEUMATOLOGY, 55(8), 1466-1476. doi:10.1093/rheumatology/kew179

    DOI: 10.1093/rheumatology/kew179

    Ghost busting-taking the sheet off the ghost (Journal article)

    Moots, R. J., Wilson, K., Silverman, E. D., & Editors, I. R. (2016). Ghost busting-taking the sheet off the ghost. CLINICAL RHEUMATOLOGY, 35(4), 841-842. doi:10.1007/s10067-016-3181-5

    DOI: 10.1007/s10067-016-3181-5

    Ghost busting-taking the sheet off the ghost (Journal article)

    Moots, R. J., Wilson, K., & Silverman, E. D. (2016). Ghost busting-taking the sheet off the ghost. RHEUMATOLOGY INTERNATIONAL, 36(4), 455-456. doi:10.1007/s00296-016-3439-x

    DOI: 10.1007/s00296-016-3439-x

    Ghostbusting-taking the sheet off the ghost (Journal article)

    Moots, R. J., Wilson, K., Silverman, E. D., & Editors, I. R. (2016). Ghostbusting-taking the sheet off the ghost. RHEUMATOLOGY, 55(4), 597-598. doi:10.1093/rheumatology/kev370

    DOI: 10.1093/rheumatology/kev370

    New insights into neutrophil phenotype in rheumatoid arthritis using RNA-Seq (Conference Paper)

    Wright, H. L., Moot, R. J., & Edwards, S. W. (2016). New insights into neutrophil phenotype in rheumatoid arthritis using RNA-Seq. In EUROPEAN JOURNAL OF CLINICAL INVESTIGATION Vol. 46 (pp. 72). Retrieved from http://gateway.webofknowledge.com/

    Eligibility for clinical trials in primary Sjogren's syndrome: lessons from the UK Primary Sjogren's Syndrome Registry (Journal article)

    Oni, C., Mitchell, S., James, K., Ng, W. -F., Griffiths, B., Hindmarsh, V., . . . Syndrome, U. K. P. S. (2016). Eligibility for clinical trials in primary Sjogren's syndrome: lessons from the UK Primary Sjogren's Syndrome Registry. RHEUMATOLOGY, 55(3), 544-552. doi:10.1093/rheumatology/kev373

    DOI: 10.1093/rheumatology/kev373

    Eligibility for clinical trials in primary Sjogren's syndrome: lessons from the UK Primary Sjogren's Syndrome Registry (vol 55, pg 544, 2016) (Journal article)

    Oni, C., Mitchell, S., James, K., Ng, W. -F., Griffiths, B., Hindmarsh, V., . . . Syndrome, U. K. P. S. (2017). Eligibility for clinical trials in primary Sjogren's syndrome: lessons from the UK Primary Sjogren's Syndrome Registry (vol 55, pg 544, 2016). RHEUMATOLOGY, 56(12), 2255. doi:10.1093/rheumatology/kex331

    DOI: 10.1093/rheumatology/kex331

    Ghostbusting-Taking the sheet off the ghost. (Journal article)

    Moots, R. J., Wilson, K., Silverman, E. D., & International Rheumatology Editors. (2016). Ghostbusting-Taking the sheet off the ghost.. Reumatologia clinica, 12(2), 63-64. doi:10.1016/j.reuma.2016.02.002

    DOI: 10.1016/j.reuma.2016.02.002

    Ghost busting, taking the sheet off the ghost (Journal article)

    Moots, R. J., Wilson, K., Silverman, E. D., & Editors, I. R. (2016). Ghost busting, taking the sheet off the ghost. MODERN RHEUMATOLOGY, 26(3), 321-322. doi:10.3109/14397595.2015.1135665

    DOI: 10.3109/14397595.2015.1135665

    Development of a Rheumatology-specific Patient Concerns Inventory and Its Use in the Rheumatology Outpatient Clinic Setting (Journal article)

    Ahmed, A. E., Lowe, D., Kirton, J. A., O'Brien, M. R., Mediana, A., Frankland, H., . . . Moots, R. J. (2016). Development of a Rheumatology-specific Patient Concerns Inventory and Its Use in the Rheumatology Outpatient Clinic Setting. JOURNAL OF RHEUMATOLOGY, 43(4), 779-787. doi:10.3899/jrheum.150068

    DOI: 10.3899/jrheum.150068

    Ghost Busting, Taking the Sheet Off the Ghost (Journal article)

    Moots, R. J., Wilson, K., & Silverman, E. D. (2016). Ghost Busting, Taking the Sheet Off the Ghost. JOURNAL OF RHEUMATOLOGY, 43(4), 689-690. doi:10.3899/jrheum.151278

    DOI: 10.3899/jrheum.151278

    Reporting of potential immunogenicity with biologic drugs: clarity and accuracy required (Journal article)

    Moots, R. J., Balsa, A., & Wolbink, G. (2016). Reporting of potential immunogenicity with biologic drugs: clarity and accuracy required. ANNALS OF THE RHEUMATIC DISEASES, 75(5), E24. doi:10.1136/annrheumdis-2016-209178

    DOI: 10.1136/annrheumdis-2016-209178

    Fatigue in Primary Sjogren's Syndrome (pSS) Is Associated with Lower Levels of Proinflammatory Cytokines: A Validation Study (Journal article)

    Davies, K., Mirza, K., Tarn, J., Tripp, N. H., Moots, R. J., Gendi, N., . . . Ng, W. -F. (2017). Fatigue in Primary Sjogren's Syndrome (pSS) Is Associated with Lower Levels of Proinflammatory Cytokines: A Validation Study. ARTHRITIS & RHEUMATOLOGY, 69. Retrieved from http://gateway.webofknowledge.com/

    Inflammatory arthritis in HIV positive patients: A practical guide (Journal article)

    Adizie, T., Moots, R. J., Hodkinson, B., French, N., & Adebajo, A. O. (2016). Inflammatory arthritis in HIV positive patients: A practical guide. BMC INFECTIOUS DISEASES, 16. doi:10.1186/s12879-016-1389-2

    DOI: 10.1186/s12879-016-1389-2

    2015

    A Transcriptional Signature of Fatigue Derived from Patients with Primary Sjogren's Syndrome (Journal article)

    James, K., Al-Ali, S., Tarn, J., Cockell, S. J., Gillespie, C. S., Hindmarsh, V., . . . Syndrome, U. K. P. S. (2015). A Transcriptional Signature of Fatigue Derived from Patients with Primary Sjogren's Syndrome. PLOS ONE, 10(12). doi:10.1371/journal.pone.0143970

    DOI: 10.1371/journal.pone.0143970

    Measurement of anti-drug antibodies to biologic drugs. A sexy trend-or is it clinically meaningful? (Journal article)

    Felis-Giemza, A., & Moots, R. J. (2015). Measurement of anti-drug antibodies to biologic drugs. A sexy trend-or is it clinically meaningful?. RHEUMATOLOGY, 54(11), 1941-1943. doi:10.1093/rheumatology/kev279

    DOI: 10.1093/rheumatology/kev279

    Assessment of Global Disease Activity in Rheumatoid Arthritis by Patients and Physicians: Differences Across Countries in the METEOR Database (Journal article)

    Gvozdenovic, E., Wolterbeek, R., Allaart, C. F., Brenol, C., Dougados, M., Emery, P., . . . Landewe, R. B. M. (2015). Assessment of Global Disease Activity in Rheumatoid Arthritis by Patients and Physicians: Differences Across Countries in the METEOR Database. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 21(7), 349-354. doi:10.1097/RHU.0000000000000296

    DOI: 10.1097/RHU.0000000000000296

    Incidence of Anti-Drug Antibodies in Rheumatoid Arthritis Patients Treated with Adalimumab, Etanercept, or Infliximab in a Real-World Setting (Journal article)

    Moots, R. J., Xavier, R., Mok, C. C., Rahman, M. U., Tsai, W. -C., Al Maini, M., . . . Vlahos, B. (2015). Incidence of Anti-Drug Antibodies in Rheumatoid Arthritis Patients Treated with Adalimumab, Etanercept, or Infliximab in a Real-World Setting. ARTHRITIS & RHEUMATOLOGY, 67. Retrieved from http://gateway.webofknowledge.com/

    TNF Inhibitor Use Across Countries in Two Time Periods Using the Meteor Database (Journal article)

    Salomon-Escoto, K., Kini, N., Person, S. D., da Silva, J. A. P., Ferraccioli, G., Huizinga, T. W. J., . . . Kay, J. (2015). TNF Inhibitor Use Across Countries in Two Time Periods Using the Meteor Database. ARTHRITIS & RHEUMATOLOGY, 67. Retrieved from http://gateway.webofknowledge.com/

    Whose Gene Is It Anyway? The Effect of Preparation Purity on Neutrophil Transcriptome Studies (Journal article)

    Thomas, H. B., Moots, R. J., Edwards, S. W., & Wright, H. L. (2015). Whose Gene Is It Anyway? The Effect of Preparation Purity on Neutrophil Transcriptome Studies. PLOS ONE, 10(9). doi:10.1371/journal.pone.0138982

    DOI: 10.1371/journal.pone.0138982

    Burden of dose escalation with tumour necrosis factor inhibitors in rheumatoid arthritis: a systematic review of frequency and costs (Journal article)

    Moots, R. J., Mays, R., Stephens, J., & Tarallo, M. (2015). Burden of dose escalation with tumour necrosis factor inhibitors in rheumatoid arthritis: a systematic review of frequency and costs. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 33(5), 737-745. Retrieved from http://gateway.webofknowledge.com/

    Quality indicators in rheumatoid arthritis: results from the METEOR database (Journal article)

    Navarro-Compan, V., Smolen, J. S., Huizinga, T. W. J., Landewe, R., Ferraccioli, G., da Silva, J. A. P., . . . van der Heijde, D. (2015). Quality indicators in rheumatoid arthritis: results from the METEOR database. RHEUMATOLOGY, 54(9), 1630-1639. doi:10.1093/rheumatology/kev108

    DOI: 10.1093/rheumatology/kev108

    Resveratrol and N-acetylcysteine influence redox balance in equine articular chondrocytes under acidic and very low oxygen conditions (Journal article)

    Collins, J. A., Moots, R. J., Clegg, P. D., & Milner, P. (2015). Resveratrol and N-acetylcysteine influence redox balance in equine articular chondrocytes under acidic and very low oxygen conditions. FREE RADICAL BIOLOGY AND MEDICINE, 86, 57-64. doi:10.1016/j.freeradbiomed.2015.05.008

    DOI: 10.1016/j.freeradbiomed.2015.05.008

    Behçet's disease: Review of management (Journal article)

    Nair, J. R., & Moots, R. J. (2015). Behçet's disease: Review of management. Indian Journal of Rheumatology, 10, S84-S94. doi:10.1016/j.injr.2015.09.003

    DOI: 10.1016/j.injr.2015.09.003

    A Darwinian view of Behcet's Disease (Conference Paper)

    Wallace, G. R., Roberts, A. M., Smith, R. L., Moots, R. J., & IM. (2015). A Darwinian view of Behcet's Disease. In INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE Vol. 56. Retrieved from http://gateway.webofknowledge.com/

    PREDICTION OF REMISSION AND LOW DISEASE ACTIVITY IN DMARD-REFRACTORY PATIENTS WITH RA TREATED WITH GOLIMUMAB (Conference Paper)

    Vastesaeger, N., Durez, P., Dasgupta, B., Combe, B., Schulze-Koops, H., Louw, I., . . . Govoni, M. (2015). PREDICTION OF REMISSION AND LOW DISEASE ACTIVITY IN DMARD-REFRACTORY PATIENTS WITH RA TREATED WITH GOLIMUMAB. In ANNALS OF THE RHEUMATIC DISEASES Vol. 74 (pp. 710). doi:10.1136/annrheumdis-2015-eular.3061

    DOI: 10.1136/annrheumdis-2015-eular.3061

    Pegylated interferon-alpha-2b reduces corticosteroid requirement in patients with Behcet's disease with upregulation of circulating regulatory T cells and reduction of Th17 (Journal article)

    Lightman, S., Taylor, S. R. J., Bunce, C., Longhurst, H., Lynn, W., Moots, R., . . . Haskard, D. O. (2015). Pegylated interferon-alpha-2b reduces corticosteroid requirement in patients with Behcet's disease with upregulation of circulating regulatory T cells and reduction of Th17. ANNALS OF THE RHEUMATIC DISEASES, 74(6), 1138-1144. doi:10.1136/annrheumdis-2014-205571

    DOI: 10.1136/annrheumdis-2014-205571

    Rituximab versus an alternative TNF inhibitor in patients with rheumatoid arthritis who failed to respond to a single previous TNF inhibitor: SWITCH-RA, a global, observational, comparative effectiveness study (Journal article)

    Emery, P., Gottenberg, J. E., Rubbert-Roth, A., Sarzi-Puttini, P., Choquette, D., Martinez Taboada, V. M., . . . Finckh, A. (2015). Rituximab versus an alternative TNF inhibitor in patients with rheumatoid arthritis who failed to respond to a single previous TNF inhibitor: SWITCH-RA, a global, observational, comparative effectiveness study. ANNALS OF THE RHEUMATIC DISEASES, 74(6), 979-984. doi:10.1136/annrheumdis-2013-203993

    DOI: 10.1136/annrheumdis-2013-203993

    Do the EULAR Sjogren's syndrome outcome measures correlate with health status in primary Sjogren's syndrome? (Journal article)

    Lendrem, D., Mitchell, S., McMeekin, P., Gompels, L., Hackett, K., Bowman, S., . . . Registry, U. P. S. S. (2015). Do the EULAR Sjogren's syndrome outcome measures correlate with health status in primary Sjogren's syndrome?. RHEUMATOLOGY, 54(4), 655-659. doi:10.1093/rheumatology/keu361

    DOI: 10.1093/rheumatology/keu361

    Pain reduction with oral methotrexate in knee osteoarthritis, a pragmatic phase iii trial of treatment effectiveness (PROMOTE): study protocol for a randomized controlled trial (Journal article)

    Kingsbury, S. R., Tharmanathan, P., Arden, N. K., Batley, M., Birrell, F., Cocks, K., . . . Conaghan, P. G. (2015). Pain reduction with oral methotrexate in knee osteoarthritis, a pragmatic phase iii trial of treatment effectiveness (PROMOTE): study protocol for a randomized controlled trial. TRIALS, 16. doi:10.1186/s13063-015-0602-8

    DOI: 10.1186/s13063-015-0602-8

    Synovial fluid IL-6 concentrations associated with positive response to tocilizumab in an RA patient with failed response to anti-TNF and rituximab (Journal article)

    Wright, H. L., Mewar, D., Bucknall, R. C., Edwards, S. W., & Moots, R. J. (2015). Synovial fluid IL-6 concentrations associated with positive response to tocilizumab in an RA patient with failed response to anti-TNF and rituximab. RHEUMATOLOGY, 54(4), 743-744. doi:10.1093/rheumatology/keu488

    DOI: 10.1093/rheumatology/keu488

    Cutaneous immunopathology of long-standing complex regional pain syndrome (Journal article)

    Osborne, S., Farrell, J., Dearman, R. J., MacIver, K., Naisbitt, D. J., Moots, R. J., . . . Goebel, A. (2015). Cutaneous immunopathology of long-standing complex regional pain syndrome. EUROPEAN JOURNAL OF PAIN, 19(10), 1516-1526. doi:10.1002/ejp.685

    DOI: 10.1002/ejp.685

    Differential changes in gene expression in human neutrophils following TNF-α stimulation: Up-regulation of anti-apoptotic proteins and down-regulation of proteins involved in death receptor signaling. (Journal article)

    Chiewchengchol, D., Wright, H. L., Thomas, H. B., Lam, C. W., Roberts, K. J., Hirankarn, N., . . . Edwards, S. W. (2016). Differential changes in gene expression in human neutrophils following TNF-α stimulation: Up-regulation of anti-apoptotic proteins and down-regulation of proteins involved in death receptor signaling.. Immunity, inflammation and disease, 4(1), 35-44. doi:10.1002/iid3.90

    DOI: 10.1002/iid3.90

    Interferon gene expression signature in rheumatoid arthritis neutrophils correlates with a good response to TNFi therapy (Journal article)

    Wright, H. L., Thomas, H. B., Moots, R. J., & Edwards, S. W. (2015). Interferon gene expression signature in rheumatoid arthritis neutrophils correlates with a good response to TNFi therapy. RHEUMATOLOGY, 54(1), 188-193. doi:10.1093/rheumatology/keu299

    DOI: 10.1093/rheumatology/keu299

    Motherhood and fatherhood of patients with inflammatory rheumatic diseases in the era of biologics. Where are we after 20 years of anti-TNFs’ use? (Journal article)

    Moots, R. J., & Felis-Giemza, A. (2015). Motherhood and fatherhood of patients with inflammatory rheumatic diseases in the era of biologics. Where are we after 20 years of anti-TNFs’ use?. Reumatologia/Rheumatology, 5, 233-235. doi:10.5114/reum.2015.55823

    DOI: 10.5114/reum.2015.55823

    2014

    Interferons alter the response of neutrophils to inflammatory cytokines in vitro: implications for inflammatory disease and response to therapy (Journal article)

    Wright, H. L., Moots, R. J., & Edwards, S. W. (2014). Interferons alter the response of neutrophils to inflammatory cytokines in vitro: implications for inflammatory disease and response to therapy. IMMUNOLOGY, 143, 152. Retrieved from http://gateway.webofknowledge.com/

    Systematic review of association between vitamin D levels and susceptibility and disease activity of ankylosing spondylitis (Journal article)

    Zhao, S., Duffield, S. J., Moots, R. J., & Goodson, N. J. (2014). Systematic review of association between vitamin D levels and susceptibility and disease activity of ankylosing spondylitis. RHEUMATOLOGY, 53(9), 1595-1603. doi:10.1093/rheumatology/keu042

    DOI: 10.1093/rheumatology/keu042

    Prediction of Remission and Low Disease Activity in DMARD-Refractory Patients with RA Treated with Golimumab (Journal article)

    Vastesaeger, N., Durez, P., Dasgupta, B., Combe, B., Schulze-Koops, H., Louw, I., . . . Weng, H. H. (2014). Prediction of Remission and Low Disease Activity in DMARD-Refractory Patients with RA Treated with Golimumab. ARTHRITIS & RHEUMATOLOGY, 66, S1089. Retrieved from http://gateway.webofknowledge.com/

    Health-related utility values of patients with primary Sjogren's syndrome and its predictors (Journal article)

    Lendrem, D., Mitchell, S., McMeekin, P., Bowman, S., Price, E., Pease, C. T., . . . Syndrome, U. K. P. S. (2014). Health-related utility values of patients with primary Sjogren's syndrome and its predictors. ANNALS OF THE RHEUMATIC DISEASES, 73(7), 1362-1368. doi:10.1136/annrheumdis-2012-202863

    DOI: 10.1136/annrheumdis-2012-202863

    OBESITY AND DISEASE ACTIVITY IN A LARGE INTERNATIONAL RHEUMATOID ARTHRITIS COHORT (Conference Paper)

    Sparks, C. R., Moots, R. J., Goodson, N. J., & Fdn, M. (2014). OBESITY AND DISEASE ACTIVITY IN A LARGE INTERNATIONAL RHEUMATOID ARTHRITIS COHORT. In ANNALS OF THE RHEUMATIC DISEASES Vol. 73 (pp. 136-137). doi:10.1136/annrheumdis-2014-eular.3259

    DOI: 10.1136/annrheumdis-2014-eular.3259

    Cardiovascular Risk Factors in Women With Primary Sjogren's Syndrome: United Kingdom Primary Sjogren's Syndrome Registry Results (Journal article)

    Juarez, M., Toms, T. E., de Pablo, P., Mitchell, S., Bowman, S., Nightingale, P., . . . Syndrome, U. K. P. S. (2014). Cardiovascular Risk Factors in Women With Primary Sjogren's Syndrome: United Kingdom Primary Sjogren's Syndrome Registry Results. ARTHRITIS CARE & RESEARCH, 66(5), 757-764. doi:10.1002/acr.22227

    DOI: 10.1002/acr.22227

    INTERFERONS ALTER THE RESPONSE OF NEUTROPHILS TO INFLAMMATORY CYTOKINES IN VITRO (Conference Paper)

    Wright, H. L., Moots, R. J., & Edwards, S. W. (2014). INTERFERONS ALTER THE RESPONSE OF NEUTROPHILS TO INFLAMMATORY CYTOKINES IN VITRO. In RHEUMATOLOGY Vol. 53 (pp. 147). Retrieved from http://gateway.webofknowledge.com/

    The Long and Winding Road (Journal article)

    Moots, R. J. (2014). The Long and Winding Road. RHEUMATOLOGY, 53(3), 383-384. doi:10.1093/rheumatology/keu002

    DOI: 10.1093/rheumatology/keu002

    Effect of IL-6 and IL-6 blockade on neutrophil function in vitro and in vivo (Journal article)

    Wright, H. L., Cross, A. L., Edwards, S. W., & Moots, R. J. (2014). Effect of IL-6 and IL-6 blockade on neutrophil function in vitro and in vivo. Rheumatology. doi:10.1093/rheumatology/keu035

    DOI: 10.1093/rheumatology/keu035

    Expanded population of CD1d-restricted V alpha 24(+) cells in a patient with active rheumatoid arthritis (Journal article)

    Gutowska-Owsiak, D., Birchall, M. A., Moots, R. J., Christmas, S. E., & Pazmany, L. (2014). Expanded population of CD1d-restricted V alpha 24(+) cells in a patient with active rheumatoid arthritis. CLINICAL IMMUNOLOGY, 150(2), 140-142. doi:10.1016/j.clim.2013.11.006

    DOI: 10.1016/j.clim.2013.11.006

    The multifactorial role of neutrophils in rheumatoid arthritis (Journal article)

    Wright, H. L., Moots, R. J., & Edwards, S. W. (2014). The multifactorial role of neutrophils in rheumatoid arthritis. NATURE REVIEWS RHEUMATOLOGY, 10(10), 593-601. doi:10.1038/nrrheum.2014.80

    DOI: 10.1038/nrrheum.2014.80

    2013

    Modeling DCE-MRI at low temporal resolution: a case study on rheumatoid arthritis. (Journal article)

    Ledsam, J. R., Hodgson, R., Moots, R. J., & Sourbron, S. P. (2013). Modeling DCE-MRI at low temporal resolution: a case study on rheumatoid arthritis.. Journal of magnetic resonance imaging : JMRI, 38(6), 1554-1563. doi:10.1002/jmri.24061

    DOI: 10.1002/jmri.24061

    Effects of IL-6 and IL-6 blockade on neutrophil function in vitro and in vivo (Journal article)

    Wright, H. L., Cross, A. L., Edwards, S. W., & Moots, R. J. (2014). Effects of IL-6 and IL-6 blockade on neutrophil function in vitro and in vivo. RHEUMATOLOGY, 53(7), 1321-1331. doi:10.1093/rheumatology/keu035

    DOI: 10.1093/rheumatology/keu035

    Inhibition of pre-B cell colony-enhancing factor (PBEF/NAMPT/visfatin) decreases the ability of human neutrophils to generate reactive oxidants but does not impair bacterial killing. (Journal article)

    Roberts, K. J., Cross, A., Vasieva, O., Moots, R. J., & Edwards, S. W. (2013). Inhibition of pre-B cell colony-enhancing factor (PBEF/NAMPT/visfatin) decreases the ability of human neutrophils to generate reactive oxidants but does not impair bacterial killing.. Journal of leukocyte biology, 94(3), 481-492. doi:10.1189/jlb.1012527

    DOI: 10.1189/jlb.1012527

    Interferon gene expression signature in neutrophils from RA patients pre- and post- anti-TNF therapy. (Journal article)

    Wright, H. L., Thomas, H. B., Moots, R. J., & Edwards, S. W. (2013). Interferon gene expression signature in neutrophils from RA patients pre- and post- anti-TNF therapy.. Rheumatology, 1(52), i46.

    Oxygen and pH-sensitivity of human osteoarthritic chondrocytes in 3-D alginate bead culture system (Journal article)

    Collins, J. A., Moots, R. J., Winstanley, R., Clegg, P. D., & Milner, P. I. (2013). Oxygen and pH-sensitivity of human osteoarthritic chondrocytes in 3-D alginate bead culture system. OSTEOARTHRITIS AND CARTILAGE, 21(11), 1790-1798. doi:10.1016/j.joca.2013.06.028

    DOI: 10.1016/j.joca.2013.06.028

    Proliferatory defect of invariant population and accumulation of non-invariant CD1d-restricted natural killer T cells in the joints of RA patients (Journal article)

    Gutowska-Owsiak, D., Birchall, M. A., Moots, R. J., Christmas, S. E., & Pazmany, L. (2014). Proliferatory defect of invariant population and accumulation of non-invariant CD1d-restricted natural killer T cells in the joints of RA patients. MODERN RHEUMATOLOGY, 24(3), 434-442. doi:10.3109/14397595.2013.844309

    DOI: 10.3109/14397595.2013.844309

    RNA-seq reveals activation of both common and cytokine-specific pathways following neutrophil priming. (Journal article)

    Wright, H. L., Thomas, H. B., Moots, R. J., & Edwards, S. W. (2013). RNA-seq reveals activation of both common and cytokine-specific pathways following neutrophil priming.. PloS one, 8(3), e58598. doi:10.1371/journal.pone.0058598

    DOI: 10.1371/journal.pone.0058598

    2012

    My Life as an Editor - Robert J Moots (Journal article)

    Moots, R. J. (2012). My Life as an Editor - Robert J Moots. European Science Editing, 38(2), 50.

    Mavrilimumab, a human monoclonal GM-CSF receptor-α antibody for the management of rheumatoid arthritis: a novel approach to therapy. (Journal article)

    Nair, J. R., Edwards, S. W., & Moots, R. J. (2012). Mavrilimumab, a human monoclonal GM-CSF receptor-α antibody for the management of rheumatoid arthritis: a novel approach to therapy.. Expert opinion on biological therapy, 12(12), 1661-1668. doi:10.1517/14712598.2012.732062

    DOI: 10.1517/14712598.2012.732062

    The Relapsing Polychondritis Disease Activity Index: development of a disease activity score for relapsing polychondritis. (Journal article)

    Arnaud, L., Devilliers, H., Peng, S. L., Mathian, A., Costedoat-Chalumeau, N., Buckner, J., . . . RPDAI study group. (2012). The Relapsing Polychondritis Disease Activity Index: development of a disease activity score for relapsing polychondritis.. Autoimmunity reviews, 12(2), 204-209. doi:10.1016/j.autrev.2012.06.005

    DOI: 10.1016/j.autrev.2012.06.005

    The efficacy of biologic agents in patients with rheumatoid arthritis and an inadequate response to tumour necrosis factor inhibitors: a systematic review. (Journal article)

    Moots, R. J., & Naisbett-Groet, B. (2012). The efficacy of biologic agents in patients with rheumatoid arthritis and an inadequate response to tumour necrosis factor inhibitors: a systematic review.. Rheumatology (Oxford, England), 51(12), 2252-2261. doi:10.1093/rheumatology/kes217

    DOI: 10.1093/rheumatology/kes217

    The successful treatment of inflammatory aortitis in Behçet’s disease with Infliximab and endovascular intra-aortic stenting (Journal article)

    Lee, M. A., Kyle, S., & Moots, R. J. (n.d.). The successful treatment of inflammatory aortitis in Behçet’s disease with Infliximab and endovascular intra-aortic stenting. Rheumatology Reports, 4(1), 2. doi:10.4081/rr.2012.e2

    DOI: 10.4081/rr.2012.e2

    Musculoskeletal research--opportunities for all? (Journal article)

    Deighton, C., Symmons, D. P. M., & Moots, R. J. (2012). Musculoskeletal research--opportunities for all?. Rheumatology (Oxford, England), 51(9), 1527-1528. doi:10.1093/rheumatology/kes036

    DOI: 10.1093/rheumatology/kes036

    Stepping into the state of rheumatology in East Africa. (Journal article)

    Oyoo, O., Moots, R. J., & Ganda, B. (2012). Stepping into the state of rheumatology in East Africa.. Rheumatology (Oxford, England), 51(8), 1345-1346. doi:10.1093/rheumatology/ker411

    DOI: 10.1093/rheumatology/ker411

    Reduction of direct and indirect costs in patients with AS receiving etanercept: results from an open-label 36-week extension of the ASCEND study in four European countries. (Journal article)

    Moots, R. J., Ostor, A. J. K., Loft, A. G. R., Järvinen, P., Larsson, P., Ekelund, M., . . . Qvitzau, S. (2012). Reduction of direct and indirect costs in patients with AS receiving etanercept: results from an open-label 36-week extension of the ASCEND study in four European countries.. Rheumatology (Oxford, England), 51(2), 393-396. doi:10.1093/rheumatology/ker404

    DOI: 10.1093/rheumatology/ker404

    Working at arthritis. (Journal article)

    Short, P., Jones, A. C., Walker, D., Kavanaugh, A., & Moots, R. J. (2012). Working at arthritis.. Rheumatology (Oxford, England), 51(2), 201-203. doi:10.1093/rheumatology/ker415

    DOI: 10.1093/rheumatology/ker415

    Analysis of SF and plasma cytokines provides insights into the mechanisms of inflammatory arthritis and may predict response to therapy. (Journal article)

    Wright, H. L., Bucknall, R. C., Moots, R. J., & Edwards, S. W. (2012). Analysis of SF and plasma cytokines provides insights into the mechanisms of inflammatory arthritis and may predict response to therapy.. Rheumatology (Oxford, England), 51(3), 451-459. doi:10.1093/rheumatology/ker338

    DOI: 10.1093/rheumatology/ker338

    Autonomic symptoms are common and are associated with overall symptom burden and disease activity in primary Sjogren's syndrome. (Journal article)

    Newton, J. L., Frith, J., Powell, D., Hackett, K., Wilton, K., Bowman, S., . . . UK primary Sjögren's syndrome registry. (2012). Autonomic symptoms are common and are associated with overall symptom burden and disease activity in primary Sjogren's syndrome.. Annals of the rheumatic diseases, 71(12), 1973-1979. doi:10.1136/annrheumdis-2011-201009

    DOI: 10.1136/annrheumdis-2011-201009

    Baseline vWF factor predicts the development of elevated pulmonary artery pressure in systemic sclerosis. (Journal article)

    Barnes, T., Gliddon, A., Doré, C. J., Maddison, P., Moots, R. J., & QUINs Trial Study Group. (2012). Baseline vWF factor predicts the development of elevated pulmonary artery pressure in systemic sclerosis.. Rheumatology (Oxford, England), 51(9), 1606-1609. doi:10.1093/rheumatology/kes068

    DOI: 10.1093/rheumatology/kes068

    Discovering cytokine-specific gene expression profiles in inflammatory neutrophils using whole transcriptome sequencing (Journal article)

    Wright, H. L., Thomas, H. B., Moots, R. J., & Edwards, S. W. (2012). Discovering cytokine-specific gene expression profiles in inflammatory neutrophils using whole transcriptome sequencing. Rheumatology, 51(3), iii40.

    Neutrophil-derived reactive oxygen species in SSc. (Journal article)

    Barnes, T. C., Anderson, M. E., Edwards, S. W., & Moots, R. J. (2012). Neutrophil-derived reactive oxygen species in SSc.. Rheumatology (Oxford, England), 51(7), 1166-1169. doi:10.1093/rheumatology/ker520

    DOI: 10.1093/rheumatology/ker520

    Serine 162, an essential residue for the mitochondrial localization, stability and anti-apoptotic function of Mcl-1. (Journal article)

    Thomas, L. W., Lam, C., Clark, R. E., White, M. R. H., Spiller, D. G., Moots, R. J., & Edwards, S. W. (2012). Serine 162, an essential residue for the mitochondrial localization, stability and anti-apoptotic function of Mcl-1.. PloS one, 7(9), e45088. doi:10.1371/journal.pone.0045088

    DOI: 10.1371/journal.pone.0045088

    2011

    Rheumatology today and in the future. (Journal article)

    Moots, R. J., & Rogers, S. N. (2011). Rheumatology today and in the future.. Rheumatology (Oxford, England), 50(12), 2149-2150. doi:10.1093/rheumatology/ker386

    DOI: 10.1093/rheumatology/ker386

    Retraction. Meta-analysis of systemic lupus erythematosus and the risk of cervical neoplasia. (Journal article)

    Moots, R., & Liu, H. (2011). Retraction. Meta-analysis of systemic lupus erythematosus and the risk of cervical neoplasia.. Rheumatology (Oxford, England), 50(11), 2147. doi:10.1093/rheumatology/ker376

    DOI: 10.1093/rheumatology/ker376

    Corrections (Journal article)

    Corrections (2011). Annals of the Rheumatic Diseases, 70(8), 1519. doi:10.1136/annrheumdis-2011-70-08

    DOI: 10.1136/annrheumdis-2011-70-08

    Antinuclear antibodies and clinical associations in a british cohort with limited cutaneous systemic sclerosis. (Journal article)

    Gliddon, A. E., Doré, C. J., Dunphy, J., Betteridge, Z., McHugh, N. J., Maddison, P. J., & QUINS Trial Study Group. (2011). Antinuclear antibodies and clinical associations in a british cohort with limited cutaneous systemic sclerosis.. The Journal of rheumatology, 38(4), 702-705. doi:10.3899/jrheum.100754

    DOI: 10.3899/jrheum.100754

    'Endothelial cell activation and apoptosis mediated by neutrophil-dependent interleukin 6 trans-signalling: a novel target for systemic sclerosis?' (Journal article)

    Barnes, T. C., Spiller, D., Anderson, M. E., Edwards, S. W., & Moots, R. J. (2011). 'Endothelial cell activation and apoptosis mediated by neutrophil-dependent interleukin 6 trans-signalling: a novel target for systemic sclerosis?'. Annals of the Rheumatic Diseases, 70(2), 366-372.

    50th volume--60 years. A golden year. (Journal article)

    Scott, D. G. I., & Moots, R. J. (2011). 50th volume--60 years. A golden year.. Rheumatology (Oxford, England), 50(1), 1-3. doi:10.1093/rheumatology/keq365

    DOI: 10.1093/rheumatology/keq365

    Analysis of SF and plasma cytokines provides insights into the mechanisms of inflammatory arthritis and may predict response to therapy (Journal article)

    Wright, H. L., Bucknall, R. C., Moots, R. J., & Edwards, S. W. (2012). Analysis of SF and plasma cytokines provides insights into the mechanisms of inflammatory arthritis and may predict response to therapy. Rheumatology, 51(3), 451-459. doi:10.1093/rheumatology/ker338

    DOI: 10.1093/rheumatology/ker338

    Anatomically corresponded regional analysis of cartilage in asymptomatic and osteoarthritic knees by statistical shape modelling of the bone. (Journal article)

    Williams, T. G., Holmes, A. P., Waterton, J. C., Maciewicz, R. A., Hutchinson, C. E., Moots, R. J., . . . Taylor, C. J. (2010). Anatomically corresponded regional analysis of cartilage in asymptomatic and osteoarthritic knees by statistical shape modelling of the bone.. IEEE transactions on medical imaging, 29(8), 1541-1559. doi:10.1109/tmi.2010.2047653

    DOI: 10.1109/tmi.2010.2047653

    Differences in biologic dose-escalation, non-biologic and steroid intensification among three anti-TNF agents: evidence from clinical practice. (Journal article)

    Moots, R. J., Haraoui, B., Matucci-Cerinic, M., van Riel, P. L. C. M., Kekow, J., Schaeverbeke, T., . . . Singh, A. (2011). Differences in biologic dose-escalation, non-biologic and steroid intensification among three anti-TNF agents: evidence from clinical practice.. Clinical and experimental rheumatology, 29(1), 26-34.

    Evidence for the efficacy of complementary and alternative medicines in the management of rheumatoid arthritis: a systematic review. (Journal article)

    Macfarlane, G. J., El-Metwally, A., De Silva, V., Ernst, E., Dowds, G. L., Moots, R. J., & Arthritis Research UK Working Group on Complementary and Alternative Medicines. (2011). Evidence for the efficacy of complementary and alternative medicines in the management of rheumatoid arthritis: a systematic review.. Rheumatology (Oxford, England), 50(9), 1672-1683. doi:10.1093/rheumatology/ker119

    DOI: 10.1093/rheumatology/ker119

    Neutrophil function in inflammation and inflammatory diseases. (Journal article)

    Wright, H. L., Moots, R. J., Bucknall, R. C., & Edwards, S. W. (2010). Neutrophil function in inflammation and inflammatory diseases.. Rheumatology (Oxford, England), 49(9), 1618-1631. doi:10.1093/rheumatology/keq045

    DOI: 10.1093/rheumatology/keq045

    Relative α₁-anti-trypsin deficiency in systemic sclerosis. (Journal article)

    Barnes, T. C., Cross, A., Anderson, M. E., Edwards, S. W., & Moots, R. J. (2011). Relative α₁-anti-trypsin deficiency in systemic sclerosis.. Rheumatology (Oxford, England), 50(8), 1373-1378. doi:10.1093/rheumatology/ker123

    DOI: 10.1093/rheumatology/ker123

    The Many Faces of Interleukin-6: The Role of IL-6 in Inflammation, Vasculopathy, and Fibrosis in Systemic Sclerosis (Journal article)

    Barnes, T. C., Anderson, M. E., & Moots, R. J. (2011). The Many Faces of Interleukin-6: The Role of IL-6 in Inflammation, Vasculopathy, and Fibrosis in Systemic Sclerosis. International Journal of Rheumatology, 2011, 1-6. doi:10.1155/2011/721608

    DOI: 10.1155/2011/721608

    The many faces of interleukin-6: the role of IL-6 in inflammation, vasculopathy, and fibrosis in systemic sclerosis. (Journal article)

    Barnes, T. C., Moots, R. J., & Anderson, M. E. (2011). The many faces of interleukin-6: the role of IL-6 in inflammation, vasculopathy, and fibrosis in systemic sclerosis.. Int J Rheumatol.

    2010

    'Neutrophil reactive oxygen species generation in systemic sclerosis' (Journal article)

    Barnes, T., Anderson, M., Spiller, D., Edwards, S., & Moots, R. (2010). 'Neutrophil reactive oxygen species generation in systemic sclerosis'. Annals of the Rheumatic Diseases, 69(3), 242.

    'Systemic sclerosis serum increases endothelial cell apoptosis and activation in neutrophil-endothelial cell co-cultures: A role for interleukin-6' (Journal article)

    Barnes, T., Spiller, D., Anderson, M., Edwards, S., & Moots, R. (2010). 'Systemic sclerosis serum increases endothelial cell apoptosis and activation in neutrophil-endothelial cell co-cultures: A role for interleukin-6'. Clinical and Experimental Rheumatology.

    Changes in expression of membrane TNF, NF-{kappa}B activation and neutrophil apoptosis during active and resolved inflammation. (Journal article)

    Wright, H. L., Chikura, B., Bucknall, R. C., Moots, R. J., & Edwards, S. W. (2011). Changes in expression of membrane TNF, NF-{kappa}B activation and neutrophil apoptosis during active and resolved inflammation.. Annals of the rheumatic diseases, 70(3), 537-543. doi:10.1136/ard.2010.138065

    DOI: 10.1136/ard.2010.138065

    Endothelial activation and apoptosis mediated by neutrophil-dependent interleukin 6 trans-signalling: a novel target for systemic sclerosis? (Journal article)

    Barnes, T. C., Spiller, D. G., Anderson, M. E., Edwards, S. W., & Moots, R. J. (2011). Endothelial activation and apoptosis mediated by neutrophil-dependent interleukin 6 trans-signalling: a novel target for systemic sclerosis?. Annals of the rheumatic diseases, 70(2), 366-372. doi:10.1136/ard.2010.133587

    DOI: 10.1136/ard.2010.133587

    Improvements in patient-reported outcomes, symptoms of depression and anxiety, and their association with clinical remission among patients with moderate-to-severe active early rheumatoid arthritis. (Journal article)

    Kekow, J., Moots, R., Khandker, R., Melin, J., Freundlich, B., & Singh, A. (2011). Improvements in patient-reported outcomes, symptoms of depression and anxiety, and their association with clinical remission among patients with moderate-to-severe active early rheumatoid arthritis.. Rheumatology (Oxford, England), 50(2), 401-409. doi:10.1093/rheumatology/keq327

    DOI: 10.1093/rheumatology/keq327

    Magnetic resonance imaging and musculoskeletal ultrasonography detect and characterize covert inflammatory arthropathy in systemic sclerosis patients with arthralgia (Journal article)

    Chitale, S., Ciapetti, A., Hodgson, R., Grainger, A., O'Connor, P., Goodson, N. J., . . . Anderson, M. E. (2010). Magnetic resonance imaging and musculoskeletal ultrasonography detect and characterize covert inflammatory arthropathy in systemic sclerosis patients with arthralgia. RHEUMATOLOGY, 49(12), 2357-2361. doi:10.1093/rheumatology/keq268

    DOI: 10.1093/rheumatology/keq268

    Manifestations of systemic sclerosis necessitate a holistic approach to patient care: a case report. (Journal article)

    Moots, R. J. (2010). Manifestations of systemic sclerosis necessitate a holistic approach to patient care: a case report.. Musculoskeletal care, 8(3), 164-167. doi:10.1002/msc.179

    DOI: 10.1002/msc.179

    Neutropenia in patients receiving anti-tumor necrosis factor therapy. (Journal article)

    Hastings, R., Ding, T., Butt, S., Gadsby, K., Zhang, W., Moots, R. J., & Deighton, C. (2010). Neutropenia in patients receiving anti-tumor necrosis factor therapy.. Arthritis care & research, 62(6), 764-769. doi:10.1002/acr.20037

    DOI: 10.1002/acr.20037

    Patient-reported outcomes improve with etanercept plus methotrexate in active early rheumatoid arthritis and the improvement is strongly associated with remission: the COMET trial. (Journal article)

    Kekow, J., Moots, R. J., Emery, P., Durez, P., Koenig, A., Singh, A., . . . Sato, R. (2010). Patient-reported outcomes improve with etanercept plus methotrexate in active early rheumatoid arthritis and the improvement is strongly associated with remission: the COMET trial.. Annals of the rheumatic diseases, 69(1), 222-225. doi:10.1136/ard.2008.102509

    DOI: 10.1136/ard.2008.102509

    2009

    Changes afoot (Journal article)

    Ahmed, S., & Moots, R. J. (2010). Changes afoot. Rheumatology, 49(1), 1-2. doi:10.1093/rheumatology/kep416

    DOI: 10.1093/rheumatology/kep416

    Will treatment of rheumatoid arthritis with an IL-6R inhibitor help facilitate the 'age of remission'? (Journal article)

    Moots, R. J., Ostör, A. J., & Isaacs, J. D. (2009). Will treatment of rheumatoid arthritis with an IL-6R inhibitor help facilitate the 'age of remission'?. Expert opinion on investigational drugs, 18(11), 1687-1699. doi:10.1517/14728220903185939

    DOI: 10.1517/14728220903185939

    Rituximab for treatment of scleritis associated with rheumatoid arthritis. (Journal article)

    Chauhan, S., Kamal, A., Thompson, R. N., Estrach, C., & Moots, R. J. (2009). Rituximab for treatment of scleritis associated with rheumatoid arthritis.. The British journal of ophthalmology, 93(7), 984-985. doi:10.1136/bjo.2008.147157

    DOI: 10.1136/bjo.2008.147157

    Anti-TNF therapy leads to decreased TNF expression and NFkappaB signalling in RA neutrophils (Journal article)

    Wright, H. L., Chikura, B., Bucknall, R. C., Moots, R. J., & Edwards, S. W. (2009). Anti-TNF therapy leads to decreased TNF expression and NFkappaB signalling in RA neutrophils. Arthritis and Rheumatism, 10(60), Abstract 145. doi:10.1002/art.25228

    DOI: 10.1002/art.25228

    Behcet's syndrome. (Journal article)

    Hart, M., & Moots, R. J. (2009). Behcet's syndrome.. BMJ (Clinical research ed.), 339, b3876. doi:10.1136/bmj.b3876

    DOI: 10.1136/bmj.b3876

    Rituximab for the treatment of rheumatoid arthritis (Journal article)

    Bagust, A., Boland, A., Hockenhull, J., Fleeman, N., Greenhalgh, J., Dundar, Y., . . . Dickson, R. (2009). Rituximab for the treatment of rheumatoid arthritis. HEALTH TECHNOLOGY ASSESSMENT, 13, 23-29. doi:10.3310/hta13suppl2/04

    DOI: 10.3310/hta13suppl2/04

    Targeting oncostatin M in the treatment of rheumatoid arthritis. (Chapter)

    Barnes, T. C., & Moots, R. J. (2009). Targeting oncostatin M in the treatment of rheumatoid arthritis.. In P. P. Tak (Ed.), New Therapeutic Targets in Rheumatoid Arthritis (pp. 181-191). Basel-Boston-Berlin: Birkhauser..

    The role of neutrophil apoptosis in juvenile-onset systemic lupus erythematosus. (Journal article)

    Midgley, A., McLaren, Z., Moots, R. J., Edwards, S. W., & Beresford, M. W. (2009). The role of neutrophil apoptosis in juvenile-onset systemic lupus erythematosus.. Arthritis and rheumatism, 60(8), 2390-2401. doi:10.1002/art.24634

    DOI: 10.1002/art.24634

    You say goodbye and I say hello. (Journal article)

    Moots, R. J., & Ahmed, S. (2009). You say goodbye and I say hello.. Rheumatology (Oxford, England), 48(1), 1. doi:10.1093/rheumatology/ken444

    DOI: 10.1093/rheumatology/ken444

    2008

    Ear, nose and throat manifestations of Behçet's disease: a review. (Journal article)

    Webb, C. J., Moots, R. J., & Swift, A. C. (2008). Ear, nose and throat manifestations of Behçet's disease: a review.. The Journal of laryngology and otology, 122(12), 1279-1283. doi:10.1017/s0022215108002703

    DOI: 10.1017/s0022215108002703

    A hole in the roof. (Journal article)

    Chauhan, S., Chiu, Y., Swift, A., Griffiths, K., & Moots, R. J. (2008). A hole in the roof.. The American journal of medicine, 121(11), 960-962. doi:10.1016/j.amjmed.2008.07.014

    DOI: 10.1016/j.amjmed.2008.07.014

    Changes underlying the dynamic contrast-enhanced MRI response to treatment in rheumatoid arthritis. (Journal article)

    Hodgson, R. J., Barnes, T., Connolly, S., Eyes, B., Campbell, R. S. D., & Moots, R. (2008). Changes underlying the dynamic contrast-enhanced MRI response to treatment in rheumatoid arthritis.. Skeletal radiology, 37(3), 201-207. doi:10.1007/s00256-007-0408-1

    DOI: 10.1007/s00256-007-0408-1

    Myelodysplastic syndrome with trisomy 8 associated with Behçet syndrome: an immunologic link to a karyotypic abnormality. (Journal article)

    Thachil, J. V., Salim, R., Field, A., Moots, R., & Bolton-Maggs, P. (2008). Myelodysplastic syndrome with trisomy 8 associated with Behçet syndrome: an immunologic link to a karyotypic abnormality.. Pediatric blood & cancer, 50(3), 649-651. doi:10.1002/pbc.21075

    DOI: 10.1002/pbc.21075

    Dynamic contrast enhanced MRI of bone marrow oedema in rheumatoid arthritis. (Journal article)

    Hodgson, R., Grainger, A., O'Connor, P., Barnes, T., Connolly, S., & Moots, R. (2008). Dynamic contrast enhanced MRI of bone marrow oedema in rheumatoid arthritis.. Annals of the rheumatic diseases, 67(2), 270-272. doi:10.1136/ard.2007.077271

    DOI: 10.1136/ard.2007.077271

    'Effect of sera from patients with systemic sclerosis and Raynaud's phenomenon on neutrophil apoptosis' (Journal article)

    Naylor, E., Barnes, T., Cross, A., Anderson, M., Edwards, S., & Moots, R. (2008). 'Effect of sera from patients with systemic sclerosis and Raynaud's phenomenon on neutrophil apoptosis'. Rheumatology, 47, *.

    Abatacept: the first T lymphocyte co-stimulation modulator, for the treatment of rheumatoid arthritis. (Journal article)

    Chitale, S., & Moots, R. (2008). Abatacept: the first T lymphocyte co-stimulation modulator, for the treatment of rheumatoid arthritis.. Expert opinion on biological therapy, 8(1), 115-122. doi:10.1517/14712598.8.1.115

    DOI: 10.1517/14712598.8.1.115

    CD1d restricted NKT cells in rheumatoid arthritis (Journal article)

    Gutowska-Owsiak, D. K., Moots, R. J., Birchall, M. A., Christmas, S. E., & Pazmany, L. (2008). CD1d restricted NKT cells in rheumatoid arthritis. Immunology, 125(s1), 109.

    MRI of rheumatoid arthritis image quantitation for the assessment of disease activity, progression and response to therapy (Journal article)

    Hodgson, R. J., O'Connor, P., & Moots, R. (2008). MRI of rheumatoid arthritis image quantitation for the assessment of disease activity, progression and response to therapy. Rheumatology, 47(1), 13-21. doi:10.1093/rheumatology/kem250

    DOI: 10.1093/rheumatology/kem250

    Neutrophil cytoskeletal abnormalities in systemic sclerosis. (Journal article)

    Barnes, T., Cross, A., Naylor, E., Anderson, M., Edwards, S., & Moots, R. (2008). Neutrophil cytoskeletal abnormalities in systemic sclerosis.. Rheumatology, Suppl(47), ii304.

    Suppression of rheumatoid arthritis disease activity using 3 months of etanercept treatment does notsignificantly modify traditional CVD risk factors (Journal article)

    Fatima, F., Rao, U. R. K., Moots, R. J., & Goodson, N. J. (2008). Suppression of rheumatoid arthritis disease activity using 3 months of etanercept treatment does notsignificantly modify traditional CVD risk factors. International Journal of Rheumatic Diseases, 11(S1), 120.

    The dual effects of TNFalpha on neutrophil apoptosis are mediated via differential effects on expression of Mcl-1 and Bfl-1. (Journal article)

    Cross, A., Moots, R. J., & Edwards, S. W. (2008). The dual effects of TNFalpha on neutrophil apoptosis are mediated via differential effects on expression of Mcl-1 and Bfl-1.. Blood, 111(2), 878-884. doi:10.1182/blood-2007-05-087833

    DOI: 10.1182/blood-2007-05-087833

    Treatment of Behçet's syndrome and plasmacytoma in a patient with peripheral blood stem cell transplantation. (Journal article)

    Chauhan, S., Olujohungbe, A., & Moots, R. J. (2008). Treatment of Behçet's syndrome and plasmacytoma in a patient with peripheral blood stem cell transplantation.. Leukemia & lymphoma, 49(12), 2377-2379. doi:10.1080/10428190802474447

    DOI: 10.1080/10428190802474447

    2007

    Prevention of vascular damage in scleroderma and autoimmune Raynaud's phenomenon: a multicenter, randomized, double-blind, placebo-controlled trial of the angiotensin-converting enzyme inhibitor quinapril. (Journal article)

    Gliddon, A. E., Doré, C. J., Black, C. M., McHugh, N., Moots, R., Denton, C. P., . . . Maddison, P. J. (2007). Prevention of vascular damage in scleroderma and autoimmune Raynaud's phenomenon: a multicenter, randomized, double-blind, placebo-controlled trial of the angiotensin-converting enzyme inhibitor quinapril.. Arthritis and rheumatism, 56(11), 3837-3846. doi:10.1002/art.22965

    DOI: 10.1002/art.22965

    Recto-vaginal fistula: a refractory complication of Behcet's disease. (Journal article)

    Chawla, S., Smart, C. J., & Moots, R. J. (2007). Recto-vaginal fistula: a refractory complication of Behcet's disease.. Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland, 9(7), 667-668. doi:10.1111/j.1463-1318.2007.01217.x

    DOI: 10.1111/j.1463-1318.2007.01217.x

    Pharmacokinetic modeling of dynamic contrast-enhanced MRI of the hand and wrist in rheumatoid arthritis and the response to anti-tumor necrosis factor-alpha therapy. (Journal article)

    Hodgson, R. J., Connolly, S., Barnes, T., Eyes, B., Campbell, R. S. D., & Moots, R. (2007). Pharmacokinetic modeling of dynamic contrast-enhanced MRI of the hand and wrist in rheumatoid arthritis and the response to anti-tumor necrosis factor-alpha therapy.. Magnetic resonance in medicine, 58(3), 482-489. doi:10.1002/mrm.21349

    DOI: 10.1002/mrm.21349

    To Do No Good (Journal article)

    Walker, D. J., Ottewell, L., & Moots, R. J. (n.d.). To Do No Good. Rheumatology, 46(2), 370. doi:10.1093/rheumatology/kel385

    DOI: 10.1093/rheumatology/kel385

    Dynamic contrast enhanced MRI of bone marrow oedema in rheumatoid arthritis shows an early response to anti-TNF therapy. (Journal article)

    Hodgson, R., Grainger, A., Barnes, T., Connolly, S., O'Connor, P., & Moots, R. (2007). Dynamic contrast enhanced MRI of bone marrow oedema in rheumatoid arthritis shows an early response to anti-TNF therapy.. Arthritis and Rheumatism, 56, ii651.

    Haemophilus influenzae induces neutrophil necrosis: a role in chronic obstructive pulmonary disease? (Journal article)

    Naylor, E. J., Bakstad, D., Biffen, M., Thong, B., Calverley, P., Scott, S., . . . Edwards, S. W. (2007). Haemophilus influenzae induces neutrophil necrosis: a role in chronic obstructive pulmonary disease?. American journal of respiratory cell and molecular biology, 37(2), 135-143. doi:10.1165/rcmb.2006-0375oc

    DOI: 10.1165/rcmb.2006-0375oc

    MRI of rheumatoid arthritis image quantitation for the assessment of disease activity, progression and response to therapy. (Journal article)

    Hodgson, R. J., O'Connor, P., & Moots, R. (2008). MRI of rheumatoid arthritis image quantitation for the assessment of disease activity, progression and response to therapy.. Rheumatology (Oxford, England), 47(1), 13-21. doi:10.1093/rheumatology/kem250

    DOI: 10.1093/rheumatology/kem250

    Targeting nanomedicines in the treatment of rheumatoid arthritis: focus on certolizumab pegol (Journal article)

    Barnes, T., & Moots, R. (2007). Targeting nanomedicines in the treatment of rheumatoid arthritis: focus on certolizumab pegol. International Journal of Nanomedicine, 2(1), 3-7. doi:10.2147/nano.2007.2.1.3

    DOI: 10.2147/nano.2007.2.1.3

    Targeting nanomedicines in the treatment of rheumatoid arthritis; focus on Certolizumab pegol. (Journal article)

    Barnes, T., & Moots, R. (2007). Targeting nanomedicines in the treatment of rheumatoid arthritis; focus on Certolizumab pegol.. Journal of Nanomedicine, 2(1), 3-7.

    The Use of Non-Steroidal Anti-Inflammatories in Systemic Sclerosis (Journal article)

    Piercy, K., Moots, R. J., & Anderson, M. E. (2007). The Use of Non-Steroidal Anti-Inflammatories in Systemic Sclerosis. Arthritis & Rheumatism, 56 (9), i1222, S494.

    2006

    Influence of clinical features on the health status of patients with limited cutaneous systemic sclerosis. (Journal article)

    Gliddon, A. E., Doré, C. J., Maddison, P. J., & Quins Trial Study Group. (2006). Influence of clinical features on the health status of patients with limited cutaneous systemic sclerosis.. Arthritis and rheumatism, 55(3), 473-479. doi:10.1002/art.21999

    DOI: 10.1002/art.21999

    A patient-centred approach to drug regulation. (Journal article)

    Walker, D. J., & Moots, R. J. (2006). A patient-centred approach to drug regulation.. Rheumatology (Oxford, England), 45(8), 935-936. doi:10.1093/rheumatology/kel145

    DOI: 10.1093/rheumatology/kel145

    Induction of cancer cell apoptosis by inhibition of NF-kB and COX-2 mediated expression of Mcl-1 using time lapse imaging of individual living cells (Journal article)

    Cross, A., Thomas, L. W., White, M. R. H., Edwards, S. W., & Moots, R. J. (2006). Induction of cancer cell apoptosis by inhibition of NF-kB and COX-2 mediated expression of Mcl-1 using time lapse imaging of individual living cells. North West Cancer Research Fund (Annual Report), 1, 23.

    Neutrophil apoptosis in rheumatoid arthritis is regulated by local oxygen tensions within joints. (Journal article)

    Cross, A., Barnes, T., Bucknall, R. C., Edwards, S. W., & Moots, R. J. (2006). Neutrophil apoptosis in rheumatoid arthritis is regulated by local oxygen tensions within joints.. Journal of leukocyte biology, 80(3), 521-528. doi:10.1189/jlb.0306178

    DOI: 10.1189/jlb.0306178

    Sodium salicylate promotes neutrophil apoptosis by stimulating caspase-dependent turnover of Mcl-1 (Journal article)

    Derouet, M., Thomas, L., Moulding, D. A., Akgul, C., Cross, A., Moots, R. J., & Edwards, S. W. (2006). Sodium salicylate promotes neutrophil apoptosis by stimulating caspase-dependent turnover of Mcl-1. Journal of Immunology, 176(2), 957-965.

    Sodium salicylate promotes neutrophil apoptosis by stimulating caspase-dependent turnover of Mcl-1. (Journal article)

    Derouet, M., Thomas, L., Moulding, D. A., Akgul, C., Cross, A., Moots, R. J., & Edwards, S. W. (2006). Sodium salicylate promotes neutrophil apoptosis by stimulating caspase-dependent turnover of Mcl-1.. Journal of immunology (Baltimore, Md. : 1950), 176(2), 957-965. doi:10.4049/jimmunol.176.2.957

    DOI: 10.4049/jimmunol.176.2.957

    Therapeutic targeting of cytokines. (Journal article)

    Barnes, T., Goodacre, J., & Moots, R. J. (2006). Therapeutic targeting of cytokines.. Cytokine, 35(3-4), 217-219. doi:10.1016/j.cyto.2006.07.018

    DOI: 10.1016/j.cyto.2006.07.018

    2005

    Anti-TNF-alpha therapies: they are all the same (aren't they?). (Journal article)

    Mpofu, S., Fatima, F., & Moots, R. J. (2005). Anti-TNF-alpha therapies: they are all the same (aren't they?).. Rheumatology (Oxford, England), 44(3), 271-273. doi:10.1093/rheumatology/keh483

    DOI: 10.1093/rheumatology/keh483

    CDP-870 (certolizumab) in rheumatoid arthritis. (Journal article)

    Kaushik, V. V., & Moots, R. J. (2005). CDP-870 (certolizumab) in rheumatoid arthritis.. Expert opinion on biological therapy, 5(4), 601-606. doi:10.1517/14712598.5.4.601

    DOI: 10.1517/14712598.5.4.601

    Congenital heart block associated with undiagnosed maternal Primary Sjögren's Syndrome -- a case report and discussion. (Journal article)

    Steele, J. C., Dawson, L. J., Moots, R. J., & Field, E. A. (2005). Congenital heart block associated with undiagnosed maternal Primary Sjögren's Syndrome -- a case report and discussion.. Oral diseases, 11(3), 190-192. doi:10.1111/j.1601-0825.2005.01050.x

    DOI: 10.1111/j.1601-0825.2005.01050.x

    Cytokine medicines in clinical practice: current issues. (Journal article)

    Barnes, T., Moots, R. J., & Goodacre, J. (2005). Cytokine medicines in clinical practice: current issues.. Cytokine, 32(2), 62-66. doi:10.1016/j.cyto.2005.07.010

    DOI: 10.1016/j.cyto.2005.07.010

    Effects of Sodium Salicylate on Neutrophil Apoptosis: Acceleration of Mcl-1 Turnover (Journal article)

    Cross, A., Derouet, M., Thomas, L., & Moots, R. J. (2005). Effects of Sodium Salicylate on Neutrophil Apoptosis: Acceleration of Mcl-1 Turnover. Arthritis and Rheumatism, 44, I19.

    Leflunomide in rheumatoid arthritis: recommendations through a process of consensus. (Journal article)

    Maddison, P., Kiely, P., Kirkham, B., Lawson, T., Moots, R., Proudfoot, D., . . . Williams, E. (2005). Leflunomide in rheumatoid arthritis: recommendations through a process of consensus.. Rheumatology (Oxford, England), 44(3), 280-286. doi:10.1093/rheumatology/keh500

    DOI: 10.1093/rheumatology/keh500

    Neutrophil gene expression in rheumatoid arthritis (Journal article)

    Cross, A., Bakstad, D., Allen, J. C., Thomas, L., Moots, R. J., & Edwards, S. W. (2005). Neutrophil gene expression in rheumatoid arthritis. Pathophysiology, 12(3), 191-202. doi:10.1016/j.pathophys.2005.07.006

    DOI: 10.1016/j.pathophys.2005.07.006

    Neutrophil gene expression in rheumatoid arthritis. (Journal article)

    Cross, A., Bakstad, D., Allen, J. C., Thomas, L., Moots, R. J., & Edwards, S. W. (2005). Neutrophil gene expression in rheumatoid arthritis.. Pathophysiology, 12(3), 191-202.

    Regulation of Neutrophil Apoptosis by TNFalpha (Journal article)

    Cross, A., Derouet, M., Edwards, S. W., & Moots, R. J. (2005). Regulation of Neutrophil Apoptosis by TNFalpha. Arthritis and Rheumatism, 52(9), 480-481.

    Second International Conference on Cytokine Medicines. (Journal article)

    Barnes, T., Goodacre, J., & Moots, R. J. (2005). Second International Conference on Cytokine Medicines.. Expert opinion on biological therapy, 5(9), 1255-1258. doi:10.1517/14712598.5.9.1255

    DOI: 10.1517/14712598.5.9.1255

    The pathogenesis of systemic sclerosis - insights from the innate immune system (Journal article)

    Anderson, M. E., Cross, A., Edwards, S. W., Pazmany, L., & Moots, R. J. (2005). The pathogenesis of systemic sclerosis - insights from the innate immune system. Rheumatology, 44, i129.

    2004

    First International Conference on Cytokine Medicine, 27-28 February 2003, Manchester conference centre. (Conference Paper)

    Goodacre, J., & Moots, R. (2004). First International Conference on Cytokine Medicine, 27-28 February 2003, Manchester conference centre.. In Cytokine Vol. 28 (pp. 149-151). doi:10.1016/j.cyto.2004.07.008

    DOI: 10.1016/j.cyto.2004.07.008

    Screening for pulmonary arterial hypertension in systemic sclerosis. (Journal article)

    Busteed, S., Moots, R. J., & Thompson, R. N. (2004). Screening for pulmonary arterial hypertension in systemic sclerosis.. Rheumatology (Oxford, England), 43(10), 1315-1316. doi:10.1093/rheumatology/keh337

    DOI: 10.1093/rheumatology/keh337

    Microalbuminuria: is it a predictor of ischaemic heart disease in rheumatoid arthritis? (Journal article)

    Mpofu, S., Kaushik, V. V., Grundy, G., & Moots, R. J. (2004). Microalbuminuria: is it a predictor of ischaemic heart disease in rheumatoid arthritis?. Rheumatology (Oxford, England), 43(4), 537-538. doi:10.1093/rheumatology/keh091

    DOI: 10.1093/rheumatology/keh091

    Granulocyte macrophage colony-stimulating factor signaling and proteasome inhibition delay neutrophil apoptosis by increasing the stability of Mcl-1. (Journal article)

    Derouet, M., Thomas, L., Cross, A., Moots, R. J., & Edwards, S. W. (2004). Granulocyte macrophage colony-stimulating factor signaling and proteasome inhibition delay neutrophil apoptosis by increasing the stability of Mcl-1.. The Journal of biological chemistry, 279(26), 26915-26921. doi:10.1074/jbc.m313875200

    DOI: 10.1074/jbc.m313875200

    Magnetic resonance imaging measurement of knee cartilage volume in a multicentre study. (Journal article)

    Morgan, S. R., Waterton, J. C., Maciewicz, R. A., Leadbetter, J. E., Gandy, S. J., Moots, R. J., . . . Nash, A. F. (2004). Magnetic resonance imaging measurement of knee cartilage volume in a multicentre study.. Rheumatology (Oxford, England), 43(1), 19-21. doi:10.1093/rheumatology/keg426

    DOI: 10.1093/rheumatology/keg426

    Regulation of neutrophil apoptosis by Mcl-1. (Journal article)

    Edwards, S. W., Derouet, M., Howse, M., & Moots, R. J. (2004). Regulation of neutrophil apoptosis by Mcl-1.. Biochemical Society transactions, 32(Pt3), 489-492. doi:10.1042/bst0320489

    DOI: 10.1042/bst0320489

    Regulation of neutrophil apoptosis by Mcl-1. (Journal article)

    Edwards, S. W., Derouet, M., Howse, M., & Moots, R. J. (2004). Regulation of neutrophil apoptosis by Mcl-1.. Biochem Soc Trans., 32(3), 489-492.

    Rheumatoid Arthritis: Your Questions Answered (Book)

    Jones, N., & Moots, R. J. (2004). Rheumatoid Arthritis: Your Questions Answered. London: Churchill.

    Secretion of oncostatin M by neutrophils in rheumatoid arthritis. (Journal article)

    Cross, A., Edwards, S. W., Bucknall, R. C., & Moots, R. J. (2004). Secretion of oncostatin M by neutrophils in rheumatoid arthritis.. Arthritis and rheumatism, 50(5), 1430-1436. doi:10.1002/art.20166

    DOI: 10.1002/art.20166

    Steroids, non-steroidal anti-inflammatory drugs, and sigmoid diverticular abscess perforation in rheumatic conditions. (Journal article)

    Mpofu, S., Mpofu, C. M., Hutchinson, D., Maier, A. E., Dodd, S. R., & Moots, R. J. (2004). Steroids, non-steroidal anti-inflammatory drugs, and sigmoid diverticular abscess perforation in rheumatic conditions.. Annals of the rheumatic diseases, 63(5), 588-590. doi:10.1136/ard.2003.010355

    DOI: 10.1136/ard.2003.010355

    2003

    An unusual cause of acute renal failure in systemic sclerosis. (Journal article)

    Mpofu, S., Rhodes, J. M., Mpofu, C. M. A., & Moots, R. J. (2003). An unusual cause of acute renal failure in systemic sclerosis.. Annals of the rheumatic diseases, 62(12), 1133-1134. doi:10.1136/ard.2002.002295

    DOI: 10.1136/ard.2002.002295

    Swollen joint count as a predictor of response to anti-tumor necrosis factor alpha therapy in rheumatoid arthritis: comment on the article by Sokka and Pincus. (Journal article)

    Estrach, C., Mpofu, S., Thompson, R. N., Williams, E., Abernethy, V. E., & Moots, R. J. (2003). Swollen joint count as a predictor of response to anti-tumor necrosis factor alpha therapy in rheumatoid arthritis: comment on the article by Sokka and Pincus.. Arthritis and rheumatism, 48(12), 3611-3613. doi:10.1002/art.11335

    DOI: 10.1002/art.11335

    Treatment of respiratory complications in recalcitrant relapsing polychondritis with infliximab. (Journal article)

    Mpofu, S., Estrach, C., Curtis, J., & Moots, R. J. (2003). Treatment of respiratory complications in recalcitrant relapsing polychondritis with infliximab.. Rheumatology (Oxford, England), 42(9), 1117-1118. doi:10.1093/rheumatology/keg280

    DOI: 10.1093/rheumatology/keg280

    Treatment of Inflammatory Conditions (Patent)

    Moots, R. J., & Edwards, S. W. (2003). Treatment of Inflammatory Conditions.

    Biologic therapy in clinical practice: enthusiasm must be tempered by caution. (Journal article)

    Moots, R., Taggart, A., & Walker, D. (2003). Biologic therapy in clinical practice: enthusiasm must be tempered by caution.. Rheumatology (Oxford, England), 42(5), 614-616.

    A case of multiple sclerosis associated with rheumatoid arthritis and positive anticardiolipin antibodies. (Journal article)

    Mpofu, S., & Moots, R. J. (2003). A case of multiple sclerosis associated with rheumatoid arthritis and positive anticardiolipin antibodies.. Annals of the rheumatic diseases, 62(4), 376. doi:10.1136/ard.62.4.376

    DOI: 10.1136/ard.62.4.376

    Bilateral distal fibular and tibial stress fractures associated with heavy smoking. (Journal article)

    Mpofu, S., Moots, R. J., & Thompson, R. N. (2003). Bilateral distal fibular and tibial stress fractures associated with heavy smoking.. Annals of the rheumatic diseases, 62(3), 273-274. doi:10.1136/ard.62.3.273

    DOI: 10.1136/ard.62.3.273

    Cytostatic therapy for AA amyloidosis complicating psoriatic spondyloarthropathy. (Journal article)

    Mpofu, S., Teh, L. S., Smith, P. J., Moots, R. J., & Hawkins, P. N. (2003). Cytostatic therapy for AA amyloidosis complicating psoriatic spondyloarthropathy.. Rheumatology (Oxford, England), 42(2), 362-366. doi:10.1093/rheumatology/keg101

    DOI: 10.1093/rheumatology/keg101

    Control of Neutrophil Apoptosis in Rheumatoid Arthritis (Journal article)

    Cross, A., Moots, R. J., Bucknall, R. C., & Edwards., S. W. (2003). Control of Neutrophil Apoptosis in Rheumatoid Arthritis. Arthritis and Rheumatism, 48(9), S472.

    Natural killer cells in the synovial fluid of rheumatoid arthritis patients exhibit a CD56bright,CD94bright,CD158negative phenotype (Journal article)

    Pridgeon, C. (n.d.). Natural killer cells in the synovial fluid of rheumatoid arthritis patients exhibit a CD56bright,CD94bright,CD158negative phenotype. Rheumatology, 42(7), 870-878. doi:10.1093/rheumatology/keg240

    DOI: 10.1093/rheumatology/keg240

    Natural killer cells in the synovial fluid of rheumatoid arthritis patients exhibit a CD56bright,CD94bright,CD158negative phenotype. (Journal article)

    Pridgeon, C., Lennon, G. P., Pazmany, L., Thompson, R. N., Christmas, S. E., Christmas, S. E., & Moots, R. J. (2003). Natural killer cells in the synovial fluid of rheumatoid arthritis patients exhibit a CD56bright,CD94bright,CD158negative phenotype.. Rheumatology (Oxford, England), 42(7), 870-878. doi:10.1093/rheumatology/keg240

    DOI: 10.1093/rheumatology/keg240

    Regulation of neutrophil apoptosis. (Chapter)

    Edwards, S. W., Moulding, D. A., Derouet, M., & Moots, R. J. (2003). Regulation of neutrophil apoptosis.. In Unknown Book (Vol. 83, pp. 204-224). doi:10.1159/000071562

    DOI: 10.1159/000071562

    Swollen joint count as a predictor of response to anti-tumor necrosis factor alpha therapy in rheumatoid arthritis (Journal article)

    Estrach, C., Mpofu, S., Thompson, R. N., Williams, E., Abernethy, V. E., & Moots, R. J. (2003). Swollen joint count as a predictor of response to anti-tumor necrosis factor alpha therapy in rheumatoid arthritis. Arthritis and Rheumatism, 48(12), 3611-3613. doi:10.1002/art.11335

    DOI: 10.1002/art.11335

    Synovial fluid neutrophils transcribe and express class II major histocompatibility complex molecules in rheumatoid arthritis. (Journal article)

    Cross, A., Bucknall, R. C., Cassatella, M. A., Edwards, S. W., & Moots, R. J. (2003). Synovial fluid neutrophils transcribe and express class II major histocompatibility complex molecules in rheumatoid arthritis.. Arthritis and rheumatism, 48(10), 2796-2806. doi:10.1002/art.11253

    DOI: 10.1002/art.11253

    The mitochondrial network of human neutrophils: role in chemotaxis, phagocytosis, respiratory burst activation, and commitment to apoptosis. (Journal article)

    Fossati, G., Moulding, D. A., Spiller, D. G., Moots, R. J., White, M. R. H., & Edwards, S. W. (2003). The mitochondrial network of human neutrophils: role in chemotaxis, phagocytosis, respiratory burst activation, and commitment to apoptosis.. Journal of immunology (Baltimore, Md. : 1950), 170(4), 1964-1972. doi:10.4049/jimmunol.170.4.1964

    DOI: 10.4049/jimmunol.170.4.1964

    2002

    Is methotrexate effective in ankylosing spondylitis? (Journal article)

    Roychowdhury, B., Bintley-Bagot, S., Bulgen, D. Y., Thompson, R. N., Tunn, E. J., & Moots, R. J. (2002). Is methotrexate effective in ankylosing spondylitis?. Rheumatology (Oxford, England), 41(11), 1330-1332. doi:10.1093/rheumatology/41.11.1330

    DOI: 10.1093/rheumatology/41.11.1330

    Behçet's syndrome: response to infliximab after failure of etanercept. (Journal article)

    Estrach, C., Mpofu, S., & Moots, R. J. (2002). Behçet's syndrome: response to infliximab after failure of etanercept.. Rheumatology (Oxford, England), 41(10), 1213-1214. doi:10.1093/rheumatology/41.10.1213-c

    DOI: 10.1093/rheumatology/41.10.1213-c

    Rheumatoid arthritis (Journal article)

    Moots, R. J. (2002). Rheumatoid arthritis. Good Clinical Practice Journal, 9(1), 15.

    Control of Neutrophil Apoptosis in Rheumatoid Arthritis: Expression of Bax and Mcl-1 (Journal article)

    Cross, A., Moots, R. J., Bucknall, R., & Edwards, S. W. (2002). Control of Neutrophil Apoptosis in Rheumatoid Arthritis: Expression of Bax and Mcl-1. Arthritis and Rheumatism, 46(9), S421.

    Differential role of neutrophil Fcgamma receptor IIIB (CD16) in phagocytosis, bacterial killing, and responses to immune complexes. (Journal article)

    Fossati, G., Moots, R. J., Bucknall, R. C., & Edwards, S. W. (2002). Differential role of neutrophil Fcgamma receptor IIIB (CD16) in phagocytosis, bacterial killing, and responses to immune complexes.. Arthritis and rheumatism, 46(5), 1351-1361. doi:10.1002/art.10230

    DOI: 10.1002/art.10230

    Dopamine receptor expression on human T- and B-lymphocytes, monocytes, neutrophils, eosinophils and NK cells: a flow cytometric study (Journal article)

    McKenna, F., McLaughlin, P. J., Lewis, B. J., Sibbring, G. C., Cummerson, J. A., Bowen-Jones, D., & Moots, R. J. (2002). Dopamine receptor expression on human T- and B-lymphocytes, monocytes, neutrophils, eosinophils and NK cells: a flow cytometric study. J Neuroimmunol, 132(1-2), 34-40.

    Dopamine receptor expression on human T- and B-lymphocytes, monocytes, neutrophils, eosinophils and NK cells: a flow cytometric study. (Journal article)

    McKenna, F., McLaughlin, P. J., Lewis, B. J., Sibbring, G. C., Cummerson, J. A., Bowen-Jones, D., & Moots, R. J. (2002). Dopamine receptor expression on human T- and B-lymphocytes, monocytes, neutrophils, eosinophils and NK cells: a flow cytometric study.. Journal of neuroimmunology, 132(1-2), 34-40. doi:10.1016/s0165-5728(02)00280-1

    DOI: 10.1016/s0165-5728(02)00280-1

    Education in Parkinson's disease and rheumatoid arthritis (Journal article)

    Lees, A., & Moots, R. (2002). Education in Parkinson's disease and rheumatoid arthritis. Good Clinical Practice Journal, 9(1), 14.

    Secretion of Oncostatin M by Neutrophils in Rheumatoid Arthritis (Journal article)

    Cross, A., Moots, R. J., Bucknall, R., & Edwards, S. W. (2002). Secretion of Oncostatin M by Neutrophils in Rheumatoid Arthritis. Arthritis and Rheumatism, 46(9), S562.

    2001

    Heavy cigarette smoking and RA. (Journal article)

    Masi, A. T., Aldag, J. C., & Malamet, R. L. (2001). Heavy cigarette smoking and RA.. Annals of the rheumatic diseases, 60(12), 1154-1155. doi:10.1136/ard.60.12.1154

    DOI: 10.1136/ard.60.12.1154

    Cigarette smoking and severity of rheumatoid arthritis. (Journal article)

    Hutchinson, D., & Moots, R. (2001). Cigarette smoking and severity of rheumatoid arthritis.. Rheumatology (Oxford, England), 40(12), 1426-1427. doi:10.1093/rheumatology/40.12.1426

    DOI: 10.1093/rheumatology/40.12.1426

    Late onset Raynaud's phenomenon, hypertension, deteriorating renal function, and a fit in a middle aged woman. (Journal article)

    Hutchinson, D., & Moots, R. J. (2001). Late onset Raynaud's phenomenon, hypertension, deteriorating renal function, and a fit in a middle aged woman.. Postgraduate medical journal, 77(914), E10. doi:10.1136/pmj.77.914.e10

    DOI: 10.1136/pmj.77.914.e10

    Coffee consumption, RF, and the risk of RA. (Journal article)

    Hutchinson, D., & Moots, R. (2001). Coffee consumption, RF, and the risk of RA.. Annals of the rheumatic diseases, 60(5), 540-541. doi:10.1136/ard.60.5.540a

    DOI: 10.1136/ard.60.5.540a

    Heavy cigarette smoking is strongly associated with rheumatoid arthritis (RA), particularly in patients without a family history of RA. (Journal article)

    Hutchinson, D., Shepstone, L., Moots, R., Lear, J. T., & Lynch, M. P. (2001). Heavy cigarette smoking is strongly associated with rheumatoid arthritis (RA), particularly in patients without a family history of RA.. Annals of the rheumatic diseases, 60(3), 223-227. doi:10.1136/ard.60.3.223

    DOI: 10.1136/ard.60.3.223

    CPD Rheumatology (Journal article)

    Moots, R. J. (2001). CPD Rheumatology. CPD Rheumatology, 2(1), 2.

    The influence of current cigarette smoking on the age of onset of rheumatoid arthritis (RA) in individuals with sporadic and familial RA. (Journal article)

    Hutchinson, D., Lynch, M. P., Moots, R. J., Thompson, R. N., & Williams, E. (2001). The influence of current cigarette smoking on the age of onset of rheumatoid arthritis (RA) in individuals with sporadic and familial RA.. Rheumatology (Oxford, England), 40(9), 1068-1070. doi:10.1093/rheumatology/40.9.1068

    DOI: 10.1093/rheumatology/40.9.1068

    2000

    Devic's neuromyelitis optica: a primary autoimmune disease? (Journal article)

    Hutchinson, D., Solomon, T., & Moots, R. J. (2000). Devic's neuromyelitis optica: a primary autoimmune disease?. Rheumatology (Oxford, England), 39(2), 215-217. doi:10.1093/rheumatology/39.2.215

    DOI: 10.1093/rheumatology/39.2.215

    Diagnostic evaluation of classification criteria for RA and reactive arthritis. (Journal article)

    Hutchinson, D., & Moots, R. J. (2000). Diagnostic evaluation of classification criteria for RA and reactive arthritis.. Annals of the rheumatic diseases, 59(5), 396-397. doi:10.1136/ard.59.5.396

    DOI: 10.1136/ard.59.5.396

    Editorial (Journal article)

    Moots, R. J. (2000). Editorial. CPD Rheumatology, 1(3), 86.

    Sjögren's syndrome-time for a new approach. (Journal article)

    Dawson, L. J., Smith, P. M., Moots, R. J., & Field, E. A. (2000). Sjögren's syndrome-time for a new approach.. Rheumatology (Oxford, England), 39(3), 234-237. doi:10.1093/rheumatology/39.3.234

    DOI: 10.1093/rheumatology/39.3.234

    The use of electronic mail in biomedical communication. (Journal article)

    Costello, R., Shaw, A., Cheetham, R., & Moots, R. J. (2000). The use of electronic mail in biomedical communication.. Journal of the American Medical Informatics Association : JAMIA, 7(1), 103-105. doi:10.1136/jamia.2000.0070103

    DOI: 10.1136/jamia.2000.0070103

    1999

    An introduction to T lymphocytes in autoimmune disease (Journal article)

    Pridgeon, C., & Moots, R. J. (1999). An introduction to T lymphocytes in autoimmune disease. CPD Rheumatology, 1(2), 59-63.

    Editorial (Journal article)

    Moots, R. J. (1999). Editorial. CPD Rheumatology, 1(2), 46.

    Old drug, new tricks: haloperidol inhibits secretion of proinflammatory cytokines. (Journal article)

    Moots, R. J., Al-Saffar, Z., Hutchinson, D., Golding, S. P., Young, S. P., Bacon, P. A., & McLaughlin, P. J. (1999). Old drug, new tricks: haloperidol inhibits secretion of proinflammatory cytokines.. Annals of the rheumatic diseases, 58(9), 585-587. doi:10.1136/ard.58.9.585

    DOI: 10.1136/ard.58.9.585

    A young man with repeated thromboses. (Journal article)

    Hutchinson, D., & Moots, R. J. (1999). A young man with repeated thromboses.. Postgraduate medical journal, 75(882), 254. doi:10.1136/pgmj.75.882.254a

    DOI: 10.1136/pgmj.75.882.254a

    1998

    Outcome in systemic vasculitis. (Journal article)

    Luqmani, R., Moots, R., & Guillevin, L. (1998). Outcome in systemic vasculitis.. British journal of rheumatology, 37(12), 1362-1363. doi:10.1093/rheumatology/37.12.1362

    DOI: 10.1093/rheumatology/37.12.1362

    Intestinal permeability and inflammation in patients on NSAIDs. (Journal article)

    Sigthorsson, G., Tibble, J., Hayllar, J., Menzies, I., Macpherson, A., Moots, R., . . . Bjarnason, I. (1998). Intestinal permeability and inflammation in patients on NSAIDs.. Gut, 43(4), 506-511. doi:10.1136/gut.43.4.506

    DOI: 10.1136/gut.43.4.506

    A fistful of T cells. (Journal article)

    Moots, R. J. (1998). A fistful of T cells.. British journal of rheumatology, 37(6), 602-611. doi:10.1093/rheumatology/37.6.602

    DOI: 10.1093/rheumatology/37.6.602

    Examination of disease severity in systemic vasculitis from the novel perspective of damage using the vasculitis damage index (VDI). (Journal article)

    Exley, A. R., Bacon, P. A., Luqmani, R. A., Kitas, G. D., Carruthers, D. M., & Moots, R. (1998). Examination of disease severity in systemic vasculitis from the novel perspective of damage using the vasculitis damage index (VDI).. British journal of rheumatology, 37(1), 57-63. doi:10.1093/rheumatology/37.1.57

    DOI: 10.1093/rheumatology/37.1.57

    1995

    VITAL (Vasculitis Integrated Assessment Log) assessment of vasculitis. (Conference Paper)

    Bacon, P. A., Moots, R. J., Exley, A., Luqmani, R., & Rasmussen, N. (1995). VITAL (Vasculitis Integrated Assessment Log) assessment of vasculitis.. In Clinical and experimental rheumatology Vol. 13 (pp. 275-278).

    Genetic evidence for difference between intracellular and extracellular peptides in influenza A matrix peptide-specific CTL recognition. (Journal article)

    Matsui, M., Moots, R. J., Warburton, R. J., Peace-Brewer, A. L., Tussey, L. G., Quinn, D. G., . . . Frelinger, J. A. (1995). Genetic evidence for difference between intracellular and extracellular peptides in influenza A matrix peptide-specific CTL recognition.. Journal of immunology (Baltimore, Md. : 1950), 154(3), 1088-1096.

    1994

    Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis. (Journal article)

    Luqmani, R. A., Bacon, P. A., Moots, R. J., Janssen, B. A., Pall, A., Emery, P., . . . Adu, D. (1994). Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis.. QJM : monthly journal of the Association of Physicians, 87(11), 671-678.

    Corticosteroids: do they damage the cardiovascular system? (Journal article)

    Maxwell, S. R., Moots, R. J., & Kendall, M. J. (1994). Corticosteroids: do they damage the cardiovascular system?. Postgraduate medical journal, 70(830), 863-870. doi:10.1136/pgmj.70.830.863

    DOI: 10.1136/pgmj.70.830.863

    Liver disease in twins with Felty's syndrome. (Journal article)

    Moots, R. J., Elias, E., Hubscher, S., Salmon, M., & Emery, P. (1994). Liver disease in twins with Felty's syndrome.. Annals of the rheumatic diseases, 53(3), 202-205. doi:10.1136/ard.53.3.202

    DOI: 10.1136/ard.53.3.202

    Significance of the six peptide-binding pockets of HLA-A2.1 in influenza A matrix peptide-specific cytotoxic T-lymphocyte reactivity. (Journal article)

    Matsui, M., Moots, R. J., McMichael, A. J., & Frelinger, J. A. (1994). Significance of the six peptide-binding pockets of HLA-A2.1 in influenza A matrix peptide-specific cytotoxic T-lymphocyte reactivity.. Human immunology, 41(2), 160-166. doi:10.1016/0198-8859(94)90010-8

    DOI: 10.1016/0198-8859(94)90010-8

    1993

    BSR Poster Session a (Journal article)

    BSR Poster Session a (1993). Rheumatology, 32(suppl 1), 3-88. doi:10.1093/rheumatology/32.suppl_1.3

    DOI: 10.1093/rheumatology/32.suppl_1.3

    Cyclophosphamide and systemic vasculitis. (Journal article)

    Luqmani, R., Moots, R., Emery, P., Bacon, P. A., & Adu, D. (1993). Cyclophosphamide and systemic vasculitis.. The Quarterly journal of medicine, 86(12), 843.

    In the groove: the fine detail of antigen presentation to cytotoxic T lymphocytes. (Journal article)

    Moots, R. J. (1993). In the groove: the fine detail of antigen presentation to cytotoxic T lymphocytes.. Clinical science (London, England : 1979), 84(6), 585-591. doi:10.1042/cs0840585

    DOI: 10.1042/cs0840585

    1992

    A critical role for conserved residues in the cleft of HLA-A2 in presentation of a nonapeptide to T cells. (Journal article)

    Latron, F., Pazmany, L., Morrison, J., Moots, R., Saper, M. A., McMichael, A., & Strominger, J. L. (1992). A critical role for conserved residues in the cleft of HLA-A2 in presentation of a nonapeptide to T cells.. Science (New York, N.Y.), 257(5072), 964-967. doi:10.1126/science.1380181

    DOI: 10.1126/science.1380181

    A cross-species functional interaction between the murine major histocompatibility complex class I alpha 3 domain and human CD8 revealed by peptide-specific cytotoxic T lymphocytes. (Journal article)

    Moots, R. J., Samberg, N. L., Pazmany, L., Frelinger, J. A., McMichael, A. J., & Stauss, H. J. (1992). A cross-species functional interaction between the murine major histocompatibility complex class I alpha 3 domain and human CD8 revealed by peptide-specific cytotoxic T lymphocytes.. European journal of immunology, 22(6), 1643-1646. doi:10.1002/eji.1830220645

    DOI: 10.1002/eji.1830220645

    Identification of the nonamer peptide from influenza A matrix protein and the role of pockets of HLA-A2 in its recognition by cytotoxic T lymphocytes. (Journal article)

    Morrison, J., Elvin, J., Latron, F., Gotch, F., Moots, R., Strominger, J. L., & McMichael, A. (1992). Identification of the nonamer peptide from influenza A matrix protein and the role of pockets of HLA-A2 in its recognition by cytotoxic T lymphocytes.. European journal of immunology, 22(4), 903-907. doi:10.1002/eji.1830220404

    DOI: 10.1002/eji.1830220404

    1991

    Positioning of a peptide in the cleft of HLA-A2 by complementing amino acid changes. (Journal article)

    Latron, F., Moots, R., Rothbard, J. B., Garrett, T. P., Strominger, J. L., & McMichael, A. (1991). Positioning of a peptide in the cleft of HLA-A2 by complementing amino acid changes.. Proceedings of the National Academy of Sciences of the United States of America, 88(24), 11325-11329. doi:10.1073/pnas.88.24.11325

    DOI: 10.1073/pnas.88.24.11325

    Extensive conservation of alpha and beta chains of the human T-cell antigen receptor recognizing HLA-A2 and influenza A matrix peptide. (Journal article)

    Moss, P. A., Moots, R. J., Rosenberg, W. M., Rowland-Jones, S. J., Bodmer, H. C., McMichael, A. J., & Bell, J. I. (1991). Extensive conservation of alpha and beta chains of the human T-cell antigen receptor recognizing HLA-A2 and influenza A matrix peptide.. Proceedings of the National Academy of Sciences of the United States of America, 88(20), 8987-8990. doi:10.1073/pnas.88.20.8987

    DOI: 10.1073/pnas.88.20.8987

    A cluster of mutations in HLA-A2 alpha 2 helix abolishes peptide recognition by T cells. (Journal article)

    Moots, R. J., Matsui, M., Pazmany, L., McMichael, A. J., & Frelinger, J. A. (1991). A cluster of mutations in HLA-A2 alpha 2 helix abolishes peptide recognition by T cells.. Immunogenetics, 34(3), 141-148. doi:10.1007/bf00205816

    DOI: 10.1007/bf00205816

    Limited regions of the alpha 2-domain alpha-helix control anti-A2 allorecognition: an analysis using a panel of A2 mutants. (Journal article)

    Lombardi, G., Matsui, M., Moots, R., Aichinger, G., Sidhu, S., Batchelor, R., . . . Lechler, R. (1991). Limited regions of the alpha 2-domain alpha-helix control anti-A2 allorecognition: an analysis using a panel of A2 mutants.. Immunogenetics, 34(3), 149-156. doi:10.1007/bf00205817

    DOI: 10.1007/bf00205817

    Structural relationship between HLA-A2-restricted and anti-A2 allospecific T-cell recognition: analysis by mutation of the codons for polymorphic and conserved residues. (Conference Paper)

    Lombardi, G., Matsui, M., Moots, R., Aichinger, G., Sidhu, S., Batchelor, R., . . . Lechler, R. (1991). Structural relationship between HLA-A2-restricted and anti-A2 allospecific T-cell recognition: analysis by mutation of the codons for polymorphic and conserved residues.. In Transplantation proceedings Vol. 23 (pp. 446-448).